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REASONED OPINION 
Reasoned opinion on the setting of MRLs for saflufenacil in various crops, 
considering the risk related to the metabolite trifluoroacetic acid (TFA)
1 
European Food Safety Authority
2  
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission requested EFSA to 
perform a follow-up evaluation of saflufenacil with regard to the MRLs adopted recently by Codex Alimentarius 
Commission and the possible consumer health concerns regarding the metabolite trifluoroacetic acid (TFA). On 
the basis of the information available to EFSA and the current scientific knowledge, EFSA concludes that for the 
intended  use  of  saflufenacil  on  the  crops  for  which  MRLs  were  requested  in  the  framework  of  the  MRL 
application  (EFSA-Q-2011-00208),  including  the  CXLs  established  by  Codex  Alimentarius  Commission  in 
2012, the exposure to saflufenacil and its metabolite trifluoroacetic acid via the diet will not result in a consumer 
exposure exceeding the toxicological reference  values derived  for the parent compound saflufenacil and its 
metabolite and therefore is unlikely to pose a public health concern. 
© European Food Safety Authority, 2014. 
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SUMMARY 
In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission requested 
EFSA to perform a follow-up evaluation of saflufenacil with regard to the MRLs adopted recently by 
Codex Alimentarius Commission and the possible consumer health concerns regarding the metabolite 
trifluoroacetic acid (TFA).  
EFSA bases its assessment on the evaluation reports submitted by the EMS in the framework of the 
previous question related to setting of new MRLs for saflufenacil, the JMPR evaluation/JMPR reports, 
the UK position paper, the Danish position paper as well as the conclusions from the previous EFSA 
opinion on saflufenacil. In addition, additional information provided by the applicant on trifluoroacetic 
acid and a position paper supported by toxicological data on TFA submitted by Bayer CropScience 
were used to assess the toxicological profile of the metabolite.  
The toxicological profile of the active substance saflufenacil was assessed in the previously issued 
reasoned opinion of EFSA. The data were sufficient to derive an ADI of 0.046 mg/kg bw per day and 
an ARfD of 0.05 mg/kg bw. For the metabolite TFA, on the basis of toxicological studies that were 
made available for this assessment, EFSA concluded that it is possible to derive a tentative ADI of 
0.05 mg/kg bw per day and a tentative ARfD at the same level (0.05 mg/kg bw).  
EFSA was asked to address concerns to what extent TFA may exert local irritative effects  in the 
gastro-intestinal tract, considering that the free acid (trifluoroacetic acid) is classified and labelled as 
corrosive. Considering the pH levels in food and the low concentrations TFA will not occur as free 
acid but in form of its salt. Thus, the irritative effects observed with the free acid are of low relevance 
in the framework of this assessment.   
The  European  Commission  asked  EFSA  to  assess  the  toxicokinetics  of  TFA  following  oral 
administration, since according to the Danish position paper this information is indispensable if the 
TTC approach should be applied. EFSA concludes that lacking these studies, no final conclusions can 
be  derived.  However,  the  Danish  concern  is  considered  to  be  sufficiently  addressed  as  it  is  not 
necessary to base the risk assessment for TFA on the TTC approach but on specific toxicological 
reference values derived for TFA.  
EFSA was also requested to update the consumer risk assessment of the previously issued opinion on 
saflufenacil, taking into account the MRLs established by Codex Alimentarius Commission (CXLs) in 
July 2012 and additional information provided in the position papers of the United Kingdom and 
Denmark. Considering the argumentation presented in the position paper of the United Kingdom, 
EFSA revised its previous opinion and derived MRL proposals for coffee and potatoes (0.03 mg/kg, 
respectively). However, EFSA noted that considering the short PHI specified in the GAP for coffee 
the  EU  data  requirements  regarding  metabolism  studies  are  not  fully  addressed.  To  clarify  the 
situation, the applicant should provide further explanations if the short PHI is relevant in practice. 
Also for potatoes, further metabolism studies would be desirable to confirm the assumption that after 
desiccation use of saflufenacil the metabolic profile in roots is comparable to the one found in soya 
beans.  
EFSA  updated  the  chronic  and  acute  exposure  assessment  for  saflufenacil,  including  the  CXLs 
adopted  in  2012  and  the  MRL  proposals  for  coffee  and  potatoes.  No  consumer  concerns  were 
identified: the long-term (chronic) exposure accounted for a maximum of 3.2 % of the ADI (UK 
toddler)  while  the  short-term  (acute) exposure  did  not  exceed  10 %  of the  ARfD  for  any  of  the 
commodities for which MRL proposals were derived (maximum for bovine liver: 9.4% of the ARfD). 
On  the  basis  of  this  updated  dietary  exposure  assessment  for  saflufenacil  (including  metabolite 
M800H11 and M800H35), EFSA concludes that the MRLs derived by EFSA, including the CXLs 
adopted in 2012 in the EU legislation do not pose a consumer health concern.  Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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For TFA a comprehensive dietary consumer exposure assessment was performed as requested by the 
European Commission taking into account all sources. Thus, for the calculation of the long-term and 
short-term exposure the following sources of exposure were considered:  
  TFA residues in primary crops resulting from the use of saflufenacil; 
  TFA residues in rotational crops grown on fields previously treated with saflufenacil;   
  TFA  residues  resulting  from  other  pesticides  that  are  metabolised  to  TFA  and  where 
measurable TFA concentrations are expected in primary or rotational crops;  
  TFA residues in food resulting from environmental contaminations (see Section 4.2.3). 
To derive the input values for the exposure assessments, a conservative approach was applied using 
highest TFA concentrations described in relevant studies identified in dossiers of saflufenacil or other 
pesticides or in the public domain. Since the input values derived for the comprehensive exposure 
assessment are subject to a high level of uncertainty, the results of the exposure assessment are less 
accurate compared with standard exposure assessments. For the interpretation of the results these 
uncertainties should be born in mind, meaning that they give an indicative estimation of the order of 
magnitude of the exposure. The total calculated intake accounted for up to 5 % of the ADI. The major 
contributors in this calculation were apples (up to 1.9% of the ADI), wheat (up to 1.4% of the ADI) 
and oranges and wine grapes (both 0.6% of the ADI, respectively).  
No acute consumer risk was identified in relation to the estimated TFA concentrations in food. The 
calculated  maximum  exposure  in  percentage  of  the  ARfD  was  24.6 %  for  potatoes,  followed  by 
oranges (21.2% of the ARfD) and apples (15.7% of the ARfD).  
To  verify  the  results  of  the  dietary  exposure  assessment  it  would  be  desirable  to  generate  more 
experimental data in the framework of a monitoring programme on TFA in food.  
On  the  basis  of  the  information  available  to  EFSA  and  the  current  scientific  knowledge,  EFSA 
concludes that for the intended use of saflufenacil on the crops for which MRLs were requested in the 
framework of the MRL application (EFSA-Q-2011-00208), including the CXLs established by Codex 
Alimentarius Commission, the TFA exposure via the diet  will not result in a consumer exposure 
exceeding the toxicological reference values derived for this metabolite and therefore is unlikely to 
pose a public health concern. 
Thus EFSA proposes to amend the existing MRLs as reported in the summary table. 
SUMMARY TABLE 
Code 
number
a 
Commodity  Existing EU 
MRL 
(mg/kg) 
Proposed EU 
MRL (mg/kg) 
Justification for the proposal 
The proposed import tolerances and CXLs reported below are sufficiently supported by data and no consumer 
intake  concerns  were  identified  with  regard  to  the  residue  definition  for  risk  assessment.  Regarding  the 
metabolite TFA a separate risk assessment was performed which did not raise intake concerns.  
Enforcement residue definition for commodities of plant origin: the sum of saflufenacil, M800H11 and 
M800H35, expressed as saflufenacil 
0110000  Citrus fruit  0.01* 
(default 
MRL) 
0.03*  Import  tolerance  for  grapefruit, 
oranges,  lemons  assessed  in 
EFSA Journal 2012;10(2):2596, 
CXL
b for whole group of citrus  Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Code 
number
a 
Commodity  Existing EU 
MRL 
(mg/kg) 
Proposed EU 
MRL (mg/kg) 
Justification for the proposal 
0120000  Tree nuts  0.03*  Import  tolerance  for  almonds 
and  pecans  assessed  in  EFSA 
Journal 2012;10(2):2596, CXL
b 
for whole group of tree nuts 
0130000  Pome fruit  0.03*  Import tolerance for apples and 
pears assessed in EFSA Journal 
2012;10(2):2596,  CXL
b  for 
whole group of pome fruit 
0140000  Stone fruit  0.03*  Import  tolerance  for  cherries, 
peaches  and  plums  assessed  in 
EFSA Journal 2012;10(2):2596, 
CXL
b for whole group of stone 
fruit 
0151000  Table and wine grapes   0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0163020  Banana   0.03*
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0163030  Mangoes  0.03*
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0211000  Potatoes  0.03*  Import tolerance re-evaluated in 
this reasoned opinion 
0234000  Sweet corn   0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0260000  Legume vegetables (fresh)  0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0300010  Dry beans  0.5
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0300030  Dr peas  0.1
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0401070  Soya bean  0.1
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0401050  Sunflower seed   1.0
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0401060  Rape seed  0.6  CXL established in 2012  
0401090  Cotton seed  0.3  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0500000 
(except 
0500020) 
Cereals  (except 
buckwheat) 
0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0900020  Sugarcane  0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Code 
number
a 
Commodity  Existing EU 
MRL 
(mg/kg) 
Proposed EU 
MRL (mg/kg) 
Justification for the proposal 
0620000  Coffee beans  0.03*  Import tolerance re-evaluated in 
this  reasoned  opinion;  further 
explanations should be provided 
concerning  the  PHI  relevant  in 
practice  to  confirm  that  the 
metabolism  studies  are 
representative for the use.  
Enforcement residue definition for commodities of animal origin: saflufenacil 
1011010 
1011020 
Swine meat 
Swine fat 
0.01* 
(default 
MRL) 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1011030 
1011040 
Swine liver 
Swine kidney 
0.3  For  liver  the  import  tolerance 
was  derived  in  EFSA  Journal 
2012;10(2):2596, for kidney the 
CXL should be taken over.   
1012010 
1013010 
1014010 
Bovine meat 
Sheep meat 
Goat meat 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1012020 
1013020 
1014010 
Bovine fat 
Sheep fat 
Goat fat 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1012030 
1013030 
1014030 
Bovine liver 
Sheep liver 
Goat liver 
0.6  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1012040 
1013040 
1014040 
Bovine kidney 
Sheep kidney 
Goat kidney 
0.3  CXL derived in 2012.  
1016000  Poultry  meat,  fat,  liver, 
kidney, edible offal 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1020000  Milk  0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1030000  Eggs  0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
(*):  Indicates that the MRL is set at the limit of analytical quantification. 
(a):  According to Annex I of Regulation (EC) No 396/2005. 
 Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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BACKGROUND 
In February 2012, EFSA published a Reasoned Opinion on the setting of new MRLs for saflufenacil in 
a wide range of food commodities (EFSA, 2012a) based on an import tolerance request from BASF 
which was submitted to the Evaluating Member State (EMS) United Kingdom. In the EU currently no 
uses are registered for this active substance. In its opinion, EFSA highlighted that there were no 
consumer health concerns for saflufenacil; a consumer risk assessment for trifluoroacetic acid (TFA), 
a metabolite of saflufenacil, could not be performed as further data on the toxicological profile would 
be needed. For TFA no Acceptable Daily Intake (ADI) and Acute Reference Dose (ARfD) could be 
derived so far. TFA is a metabolite that comes also from other sources, e.g. as metabolite form other 
active substances.  
The issue was discussed with the Member States at several meetings of the Standing Committee on the 
Food  Chain  and  Animal  Health  (SCFCAH)  where  additional  information  on  saflufenacil  was 
presented in a position paper of the United Kingdom (United Kingdom, 2012). Additional information 
was also recently provided by Denmark (Denmark, 2013). Member States delegations indicated that 
there was a need to assess consumer exposure to TFA from all sources, and that the threshold of 
toxicological concern (TTC) approach should be considered. The principles for the TTC approach 
have  been  outlined  in  the  recent  EFSA  Opinion  on  evaluation  of  the  toxicological  relevance  of 
pesticides metabolites for dietary risk assessment (EFSA, 2012b).  
Furthermore,  in  July  2012,  the  Codex  Alimentarius  Commission  adopted  several  CXLs  for 
saflufenacil for which EFSA provided an evaluation to the European Commission (EFSA, 2012c).  
On 11 June 2013 the European Commission submitted a request to EFSA to perform a follow-up 
evaluation of saflufenacil with regard to the recently adopted CXLs and the possible consumer health 
concerns regarding the metabolite TFA. The request was included in the EFSA Register of Questions 
with the reference number EFSA-Q-2013-00432 and the following subject:  
Request of a scientific opinion on the setting of MRLs for saflufenacil 
EFSA proceeded with the preparation of the reasoned opinion.  
While EFSA was working on the detailed assessment, the European Commission informed EFSA on 
31 October 2013 that specific toxicological studies for TFA will be made available by Bayer Crop 
Science.  These  data  were  submitted  to  EFSA  on  6  November  2013  and  11  November  2013. 
Considering the late submission of the toxicological studies on TFA, EFSA agreed with the European 
Commission that the originally agreed deadline needed to be extended to 15 February 2014.  
On 22 January 2014 EFSA circulated the draft reasoned opinion to consult Member State experts on 
the proposed toxicological reference values derived for trifluoroacetic acid and the other questions 
addressed in the document. All comments received by 31 January 2014 were considered by EFSA in 
the final reasoned opinion.  
TERMS OF REFERENCE 
In accordance with Article 43 of Regulation (EC) No 396/2005, the European Commission asked 
EFSA to update the reasoned opinion on saflufenacil adopted in February 2012 (EFSA, 2012a), taking 
into account the new information provided by the United Kingdom and Denmark as well as the CXLs 
adopted in 2012.  
In particular the update should address 
  the consumer exposure to the metabolite trifluoroacetic acid (TFA) from all sources, taking 
into account the principles for assessment as described in the recent EFSA Scientific Opinion Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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on  evaluation  of  the  toxicological  relevance  of  pesticide  metabolites  for  dietary  risk 
assessment (EFSA, 2012b); 
  potential irritative effects of TFA on the gastro-intestinal-tract following ingestion; 
  toxicokinetics of TFA following oral administration.  
(Terms of Reference taken over from mandate submitted by European Commission on 11 June 2013) 
APPROACH TO ASSESS THE REQUEST 
Due to the complexity of the request, EFSA has broken down the terms of reference in the following 
questions which will be discussed in detail in the following sections: 
1.   Mammalian toxicology:  
1a: Availability of data in regard to deriving an ADI and an ARfD for trifluoroacetic acid, 
considering the additional information provided by the European Commission on 6 November 
2013 and 11 November 2013;  
1b: If no toxicological reference values can be derived from empirical data, clarification if 
TFA fulfils the criteria defined for using the TTC approach and proposal of a threshold of 
toxicological concern for acute and chronic effects;  
1c: Assessment if the available data are sufficient to conclude on potential irritative effects of 
TFA  on  the  gastro-intestinal-tract  following  ingestion,  taking  into  account  the  expected 
concentrations of TFA in food treated with saflufenacil; 
1d: Assessment of the toxicokinetics of TFA following oral administration;   
2.   Evaluation of the data for coffee beans and potatoes with regards to deriving a MRL proposal 
for saflufenacil for these crops, taking into account the considerations presented in the UK 
position paper;  
3.  Exposure assessment/risk assessment saflufenacil:  
  Assessment of the recently adopted CXLs for saflufenacil regarding the consumer exposure. If 
necessary/appropriate,  the  dietary  risk  assessment  has  to  be  updated,  including  the  risk 
assessment values for the recently adopted CXLs, as well as the data on potatoes and coffee. 
4.   Exposure assessment/risk assessment TFA: 
  4a: Identification of possible sources of exposure to TFA;  
  4b: Estimation of the overall expected dietary exposure to TFA, resulting from all sources of 
exposure;  
  4c: Assessment of the overall expected dietary consumer exposure to TFA, conclusion on the 
risk for consumer health.   
ASSESSMENT 
EFSA bases its assessment on the evaluation reports submitted by the EMS in the framework of the 
previous  question  related  to  setting  of  new  MRLs  for  saflufenacil  (EFSA-Q-2011-00208;  United 
Kingdom, 2011a, 2011b), the JMPR evaluation/JMPR report (FAO, 2011a, 2011b, 2012), the UK 
position paper (United Kingdom, 2012), the Danish position paper (Denmark, 2013) as well as the Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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conclusions from the previous EFSA opinion on saflufenacil (EFSA, 2012a). In addition, a document 
provided  by  the  applicant  on  trifluoroacetic  acid  (TFA:  Environmental  and  Consumer  Safety 
Considerations  arising  from  Saflufenacil  Agricultural  Uses)  (BASF,  2011)  and  a  position  paper 
supported by toxicological data on TFA submitted by Bayer CropScience (Bayer CropScience, 2013) 
were used to assess the toxicological profile of the metabolite.  
In order to identify all sources of consumer exposure for TFA, EFSA performed a systematic literature 
review  (see  Appendix  D).  In  addition,  data  submitted  in  the  framework  of  the  peer  review  and 
previously issued reasoned opinions and EFSA conclusions were screened to identify which pesticides 
might be a source for TFA exposure.  
The assessment is performed in accordance with the legal provisions of the Uniform Principles for the 
Evaluation and the Authorisation of Plant Protection Products adopted by Commission Regulation 
(EU) No 546/2011
3 and the currently applicable guidance documents relevant for the consumer risk 
assessment of pesticide residues (EC, 1996, 1997a, 1997b, 1997c, 1997d, 1997e, 1997f, 1997g, 2000, 
2010a, 2010b, 2011; OECD, 2011). 
1.  Mammalian toxicology 
1.1.  Derivation of toxicological reference values (ADI and ARfD) for TFA 
In  order  to  decide  whether  sufficient  data  are  available  to  derive  an  ADI  and  an  ARfD  for 
trifluoroacetic  acid,  EFSA  assessed  the  additional  information  and  studies  provided  by  Bayer 
CropScience  in  November  2013  (Bayer  CropScience,  2013)  and the  information  provided  by  the 
applicant (BASF, 2011).  
According to a position paper of the applicant, trifluoroacetic is classified and labelled as corrosive 
and has not been tested for eye or skin irritation in animals (BASF, 2011).  
The intraperitoneal (i.p.) LD50 for TFA (sodium salt) was >2,000 mg/kg bw in mice. In comparative 
acute toxicity experiments, the free acid was shown to be much more acutely toxic than the sodium 
salt. The sodium salt of TFA was administered to 10 male rats as single oral dose of either 10 or 25 
mg/kg bw and caused no observable effects on the testes or on body weight. In a gavage experiment, 
no effects on liver or body weights were observed in rats administered TFA by gavage for 8 days. The 
NOAEL in this study was 950 mg/kg bw (Blake et al, 1970). 
Male Wistar rats were fed TFA
4 for 5-14 days: a dose of 500 mg/kg bw per day did not affect body 
weight, but caused a slight increase in liver weight. TFA was not considered a significant peroxisome 
proliferating chemical (Just et al, 1989). 
Groups of pregnant Sprague-Dawley rats were exposed to either 75 or 150 mg/kg bw per day TFA 
(free acid), by gavage, on gestational days 10 -20. TFA did not affect litter size, neonatal survival or 
postnatal  growth.  In  both  dose  groups,  mino r  and  transient  (only  on  PND  3) effects in liver 
biochemistry  were  noted  by  changes  in  serum  glutamate  dehydrogenase  and  aspartate 
aminotransferase activities. Additionally, a transient (PND 3 only) effect on the kidneys was observed 
as an increase in the urinary excretion of  2-microglobulin in the high-dose pups. No other effects on 
kidneys were noted. In dams, liver weights were statistically significantly increased in both treatment 
groups (123% of control in low-dose and 122% of control in high-dose dams). However, the increased 
liver weights were not dose-related and may have been related to dehydration resulting from dosing 
with the free TFA acid (Saillenfait, 1996). 
                                                       
3 Commission Regulation (EU) No 546/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European 
Parliament and of the Council as regards uniform principles for evaluation and authorisation of plant protection products. 
OJ L 155, 11.06.2011, p. 127-175. 
4 Not specified if the test material was TFA free acid or a salt. Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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As the raw data of the studies assessed in the position papers of BASF are not available to EFSA, an 
in-depth analysis of the toxicological effects and an assessment of the acceptability of the studies 
cannot be done. Therefore the above data cannot be considered for deriving reference values, but only 
as supportive data. 
According to the UK assessment (United Kingdom, 2012), in repeated dose studies the effects which 
occurred between 75 and 750 mg/kg bw included changes in liver weight, liver serum enzymes and 
liver histopathology. Based on these studies it was not possible to derive a robust sub acute NOAEL, 
which could be used to derive a chronic reference dose. Studies published in open literature and in the 
REACH  Dossier  show  no  evidence  for  a  mutagenic  or  clastogenic  potential  of  TFA/sodium 
trifuoroacetate. 
The findings of the studies provided by Bayer CropScience (2013) are summarised in Table 1-1.  
TFA (sodium salt) is not acutely toxic via oral route, not genotoxic and not toxic to developments in 
rats. After repeated exposure to rats, the liver was the target organ (increased liver  weight due to 
hepatocellular hypertrophy based on peroxisome proliferation). A NOAEL of 10 and 12 mg/kg bw per 
day in male and female rats, respectively, was established after 90-day oral exposure. The lowest 
NOAEL of 10 mg/kg bw per day was considered appropriate to derive the ADI, with the application of 
an uncertainty factor of 100 for intra- and inter-species variation plus an additional factor of 2 to 
extrapolate from subchronic to chronic study duration, resulting in a proposed ADI of 0.05 mg/kg bw 
per day. As for the ARfD, in the absence of an appropriate single exposure toxicity study the NOAEL 
of 43 mg/kg bw per day from a 14-day rat dietary toxicity study was considered the most appropriate 
and conservative, resulting in an ARfD of 0.43 mg/kg bw, by applying an uncertainty factor of 100 
(Bayer CropScience, 2013).  
Table 1-1: Summary results of toxicological studies provided by Bayer CropScience in support of the 
application for saflufenacil 
Study type   Dose tested   Result   Reference   Acceptability 
Acute oral (gavage) rat   2000 mg/kg bw   LD50 >2000 mg/kg bw   M-444479-
01-1  
Yes 
Ames  test  (S. 
typhimurium  TA98, 
TA100,  TA1535, 
TA1537, TA102)  
1.6-5000 μg/plate   Negative (+/- S9 mix)   M-256628-
01-1  
Yes 
Mammalian  cell  gene 
mutation  test  (mouse 
lymphoma L5178Y cells)  
360-1360 μg/mL   Negative (+/- S9 mix)   M-260699-
01-1  
Yes 
Mammalian chromosome 
aberration  test  (human 
lymphocytes)  
85-1360 μg/mL   Negative (+/- S9 mix)   M-260807-
01-1  
Yes 
14-day  oral  (dietary)  rat 
(mechanistic)  
0-600-1200-2400  ppm 
(males:  0-43-85-170 
mg/kg  bw  per  day; 
females:  0-45-91-190 
mg/kg bw per day)  
NOAEL:  
males:    43  mg/kg  bw 
per day  
females: 190 mg/kg bw 
per day  
M-202165-
01-1  
No (not GLP) 
28-day oral (dietary) rat   0-600-1800-5400-16000 
ppm  (males:  0-50-149-
436-1315 mg/kg bw per 
day;  females:  0-52-157-
457-1344 mg/kg bw per 
day)  
NOEL:  
males: 50mg/kg bw per 
day   
females:  52mg/kg  bw 
per day  
M-259106-
01-1  
Yes Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
 
EFSA Journal 2014;12(2):3585  11 
 
Study type   Dose tested   Result   Reference   Acceptability 
90-day oral (dietary) rat   0-160-1600-16000  ppm 
(males:  0-10-98-1043 
mg/kg  bw  per  day; 
females:  0-12-123-1216 
mg/kg bw per day)  
NOAEL: 
 males:  10  mg/kg  bw 
per day   
females: 12  mg/kg bw 
per day  
M-283994-
01-1  
Yes 
Developmental  toxicity 
rat   
0-37.5-75-150 mg/kg bw 
per day  
NOAEL: 
maternal:  150  mg/kg 
bw per day  
foetal: 150  mg/kg bw 
per day  
M-411209-
01-1  
The 
acceptability 
cannot  be 
assessed  as 
the  raw  data 
are  not 
available 
 
Among the active substances assessed in the peer review where TFA was identified in metabolism 
studies, only limited information as regards hazard characterisation of TFA is available.  
Flurtamone was approved in 2004; TFA was considered for its relevance a groundwater metabolite. 
TFA was considered not a skin and eye irritant, and as a non-genotoxic substance; when tested at level 
up to 150-400 mg/kg it showed moderate acute toxicity. Administered in the rat diet for 14 or 28 days, 
TFA induced no relevant toxicity at 750 mg/kg bw per day. In the case of flurtamone the ADI of the 
parent compound (0.03 mg/kg bw per day) was considered adequate to cover the toxicity of TFA.  
Fluazinam was approved in 2009; a data gap was identified as regards the toxicological properties of 
the plant metabolite TFA, also in comparison with the toxicity of fluazinam. 
1.1.1.  Setting of reference doses 
The approach to derive the ADI of 0.05 mg/kg bw per day as proposed in the position paper submitted 
by Bayer CropScience (Bayer CropScience, 2013) is agreed: the relevant NOAEL from the subchronic 
study in rodents and the application of an extra uncertainty factor (UF) of 2 in consideration of the 
potential chronic toxicity are appropriate. 
With regard to the ARfD, Bayer CropScience proposed to use the NOAEL of 43 mg/kg bw derived 
from the 14-day oral study in rats. However, no rationale is given for the selection of this study end 
point. EFSA is of the opinion that this study is not appropriate since it is not a GLP study. It is 
acknowledged that in none of the submitted studies there is an indication of the need to set an ARfD, 
however key studies for this purpose are missing (e.g. an acute neurotoxicity study, reproductive and 
developmental toxicity studies). Therefore it is appropriate to include an extra UF to the standard 100; 
the reference point could be the same as for the ADI, in the absence of any further indication. The 
application  of  an  additional  UF  of  2,  the  same  applied  for  setting  the  ADI,  seems  appropriate 
considering that this approach would lead to an ARfD value at the same level as the ADI, which can 
be regarded as a conservative approach. 
Table 1-1:  Overview of the proposed toxicological reference values 
  Source  Year  Value  Study relied upon  Uncertainty 
factor 
Trifluoroacetic acid 
ADI  EFSA  2014  0.05 mg/kg bw 
per day 
90 d oral rat study  200* 
ARfD  EFSA  2014  0.05 mg/kg bw  90 d oral rat study  200° Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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(*): An extra uncertainty factor (UF) of 2 is applied to the standard 100 to account for the potential chronic toxicity (no 
assays available). 
(°): An extra uncertainty factor (UF) of 2 is applied to the standard 100 to account for the incomplete toxicological database. 
 
Since the data were sufficient to derive tentative toxicological reference values, the application of the 
TTC approach as proposed in the mandate of the European Commission is not necessary.  
1.2.  Assessment of potential irritative effects of TFA on the gastro-intestinal-tract following 
ingestion 
In the position paper provided by BASF it is reported that trifluoroacetic acid is classified and labelled 
as corrosive and has not been tested for eye or skin irritation in animals (BASF, 2011). 
Considering that at the pH levels which are expected for food, TFA will not occur as free acid (pKa 
0.23) but in form of its salts (while the classification refers to the free acid), it is highly unlikely that 
the concentration of TFA expected in food could impact on the pH of food and hence no significant 
irritative effect is expected. 
1.3.  Toxicokinetics of TFA following oral administration 
Denmark raised concerns regarding the lack of information on the half-lives and kinetics of TFA since 
no data are available investigating TFA toxicokinetics following oral administration (Denmark, 2013).  
According to the position paper of the UK (United Kingdom, 2012) there is limited information on the 
half-lives and kinetics of TFA: the elimination half-life after intravenous injection to rabbits with or 
without  bile  fistulae  was 15.6  or  34.4  hours, respectively.  Rabbits  with  bile fistulae,  which  were 
administered TFA internally through a duodenal cannula showed rapid appearance in the circulating 
blood, with an elimination half-life of 16.8 hours.  
Two  reviews  of  anaesthetics  have  been  published  by  European  Centre  for  Ecotoxicology  and 
Toxicology  of  Chemicals  (ECETOC,  1996,  2006).  In  particular  for  dichlorotrifluoroethane,  an 
extensive part is dedicated to the toxicokinetics of this compound, including data on TFA. However, 
the ADME (Absorption, Distribution, Metabolism and Excretion) studies as well as other toxicological 
studies are performed via inhalation exposure, and, as such, not relevant to the present purpose. 
Denmark was of the opinion that a clear understanding of the toxicokinetic is indispensable if the TTC 
approach is applied (Denmark, 2013). EFSA concludes that as sufficient toxicological studies are 
available to derive toxicological reference values for TFA, the information is no longer required.  
2.  Setting of MRLs for coffee beans and potatoes 
2.1.  Coffee beans 
The basis of the import tolerance request for coffee beans were the GAP from Brazil (3 applications of 
25 to 50 g/ha, PHI 7 days) and the GAP from Costa Rica and Ecuador (4 applications of 100 g/ha, PHI 
0 or 1 d) (Appendix A to EFSA, 2012a). 
2.1.1.  Metabolism studies representative for coffee beans 
In the previous assessment EFSA concluded that for coffee beans no adequate metabolism studies 
were available (EFSA, 2012a). 
EFSA notes that in the EU guidance document on plant metabolism (EC, 1997a), coffee beans are not 
specifically assigned to one of the main crop groups which are normally used to investigate plant 
metabolism. However, taking into account botanical considerations, EFSA considered coffee beans as 
a  crop  represented  by  fruits  and  fruiting  vegetables.  The  metabolism  study  on  tomatoes  was  not 
representative  for the reported  GAP  in  coffee  beans  since  in  this study  the  active  substance  was Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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applied  to  the  soil  surface  before  the  tomato  plants  were  transplanted  and  it  was  therefore  not 
reflecting the short PHI specified in the GAPs reported for coffee beans. 
In the UK position paper (United Kingdom, 2012) it was proposed to use the soya bean metabolism 
study  to  support  of  the  MRL  request  for  coffee  beans.  This  proposal  is  in  line  with  the  OECD 
guideline on metabolism in crops (OECD, 2007), which classifies coffee beans in the group of pulses 
and oilseeds. For soya beans two metabolism studies were available (EFSA, 2012a), one study with 
pre-emergence  application  to  the  soil  40  days  after  planting  (uracil  and  phenyl  labelled  active 
substance) and a second study with a desiccation use 7 days before the harvest (uracil labelled active 
substance). EFSA is of the opinion that both studies have similar deficiencies as the metabolism study 
in tomatoes, i.e. the GAP for coffee beans is not reflected in terms of timing of the application and the 
PHI. According to the Brazilian GAP saflufenacil is applied 3 times as post-emergence treatment with 
a PHI of 7 days while according to the GAP of Costa Rica and Ecuador the product is applied 4 times 
post-emergence with a PHI of 0 or 1 day. 
However,  considering  that  saflufenacil  is  a  herbicide  which  exhibits  phytotoxic  effects  on  broad 
leaved plants, the pesticide application in coffee cultivation shall not be targeted to the crop but rather 
on the soil to destroy weeds. It is noted that the short PHI might not be a realistic situation in practice. 
Thus, taking also into account the low residues in the crop, it can be agreed on a provisional basis that 
the metabolism studies performed on other crops with longer PHI are extrapolated to coffee beans. 
EFSA concludes that although the EU data requirements as regards the metabolism study relevant for 
coffee beans are not fully addressed, the residue definitions proposed in the previous issued reasoned 
opinion  might  be  acceptable  also  for  coffee  beans  on  a  provisional  basis  (sum  of  saflufenacil, 
M800H11 and M800H35, expressed as saflufenacil). The applicant should however, provide further 
explanations on the GAP, in particular to specify why a short PHI of 0 to 7 days is required in coffee 
beans for a herbicide use.  
2.1.2.  Residue trials representative for coffee beans 
In  2012,  EFSA  received  three  GAP  compliant  trials  reflecting  the  Brazilian  GAP  and  five  trials 
representative for the GAP of Costa Rica and Ecuador (GAPs see Appendix A). In none of the trials 
residues  of  saflufenacil  and  the  relevant  metabolites  M800H11  and  M800H35  were  detected  in 
concentrations above the limit of quantification (< 0.01 mg/kg for each of the compounds included in 
the residue definition). In its previous opinion EFSA was of the opinion that the number of trials was 
not sufficient to derive a MRL proposal (EFSA, 2012a). 
Considering the argumentation in the UK position paper (UK, 2012), EFSA reconsidered its previous 
conclusions on the residue trials. EFSA concludes that the trials are sufficient to demonstrate a no 
residue situation and thus a MRL of 0.03 mg/kg (equivalent to the limit of quantification) is proposed. 
The  mean  and  highest  residue  to  be  considered  for  the  dietary  risk  assessment  is  0.03  mg/kg, 
respectively.  
It is noted that no data are available regarding the TFA concentration in coffee beans treated according 
to the notified GAPs.  
2.2.  Potatoes 
The basis of the import tolerance request for potatoes was the GAP from Brazil (1 application of 
100 g/ha, PHI 7 days – desiccation use) (Appendix A).  
2.2.1.  Metabolism studies representative for potatoes 
EFSA concluded in its previous assessment that the available metabolism studies sufficiently address 
the residue profile expected in all crop groups after soil application and after foliar application in 
pulses and oilseeds. However, the metabolism in root and tuber vegetables (following desiccation use) 
was not sufficiently reflected (EFSA, 2012a). Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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In the UK position paper it was proposed to consider the findings of the metabolism study in tomatoes 
for  the  MRL  request  in  potatoes,  since  both  crops  are  high  water  containing  matrices  (United 
Kingdom, 2012). 
EFSA would like to clarify that, according to the EU guidance document on plant metabolism (EC, 
1997a)  and  the  OECD  guideline  on  crop  metabolism,  potatoes  are  classified  as  root  crops  while 
tomatoes are classified as fruits and fruiting vegetables crops. Thus, metabolism studies in tomatoes 
are normally not representative for potatoes. It should also be highlighted that on potatoes saflufenacil 
is intended to be used as desiccant, and since the metabolism study in tomatoes reflects a soil surface 
treatment, this study is not appropriate. For desiccation use a metabolism study in oilseeds (soya 
beans) is available. This study demonstrated that with the short PHI typical for desiccation uses the 
metabolism is less extensive, with parent saflufenacil being the main compound accounting for 63.7 to 
76.4%  of  the  TRR  in  stem,  pods  and  leaves.  In  seeds  parent  compound  and  the  demethylated 
metabolite  M800H02  occurred  in  similar  amounts  (ca.  25%  of  TRR,  respectively).  Although  the 
metabolism study is not representative for root crops, the study provides some evidence that no new 
metabolites are expected in desiccation uses. Thus, the residue definition derived for saflufenacil can 
be applied to potatoes on a provisional basis, considering also the low residue concentrations found in 
residue trials. However, further studies to confirm the assumption that in potatoes the metabolic profile 
is comparable to the one found in soya beans after desiccation use should be performed.  
2.2.2.  Residue trials representative for potatoes 
For potatoes in total four residue trials were submitted by the applicant which were assessed by EFSA 
in 2012 (EFSA, 2012a). In none of the trials residues of saflufenacil and the metabolites M800H11 
and M800H35 were detected in concentrations above the limit of quantification. EFSA was of the 
opinion that the number of trials was not sufficient to derive a MRL proposal for potatoes since 
potatoes are a major crop (EFSA, 2012a).  
Considering the argumentation in the UK position paper, EFSA reconsidered its previous conclusions 
on the residue trials. EFSA concludes that the trials are sufficient to demonstrate a no residue situation 
for the three compounds included in the proposed residue definition. Thus, the MRL should be set at 
the LOQ of 0.03 mg/kg on a provisional basis, pending the submission of the confirmatory data 
regarding the metabolism study in potatoes. The mean and highest residue to be considered for the 
dietary risk assessment is 0.03 mg/kg, respectively.  
3.  Exposure assessment/risk assessment saflufenacil 
In 2012, EFSA assessed the data submitted in support of the requested import tolerances for a wide 
range of commodities (EFSA, 2012a). EFSA derived MRL proposals for the proposed enforcement 
residue definition (sum of saflufenacil, M800H11 and M800H35, expressed as saflufenacil (see Table 
3-1)). For risk assessment the same residue definition was proposed.  
The JMPR evaluated saflufenacil in 2011 (FAO, 2011a, 2011b); all proposed MRLs for the residue 
definition saflufenacil were advanced and adopted by Codex Alimentarius Commission in July 2012 
(CAC, 2012).  
In 2012, JMPR assessed the use on pulses and proposed to set a group tolerance of 0.3 mg/kg for the 
whole group of pulses (FAO, 2012). Thus, the previously proposed CXLs for dry beans (0.3 mg/kg), 
dry peas (0.05 mg/kg) and soya beans (0.07 mg/kg) were recommended for revocation. In the minutes 
of the CCPR meeting a reservation of the delegation of the EU and Norway was reported as regards 
this proposal (CAC, 2013). 
In  the  following  table  (Table  3-1)  EFSA  summarises  the  MRLs  proposed  for  saflufenacil  in  the 
previous reasoned opinion of EFSA (EFSA, 2012a), the CXLs established in 2012 and 2013 and, since 
most of the requested import tolerances are based on US GAPs, the legal limits established in the USA 
for the residue definition which is identical with the residue definition derived at EU level.  Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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From this table it becomes evident that in order to update the consumer risk assessment performed by 
EFSA in the previous reasoned opinion (EFSA; 2012a) with the CXLs adopted in 2012, the following 
crops need to be considered: citrus (other than grapefruit, oranges and lemons), tree nuts (other than 
almonds and pecans), pome fruit (other than apples and pears), stone fruit (other than cherries, peaches 
and  plums),  rape  seed,  coffee  beans,  potatoes  and  certain  edible  offals  (mammalian).  All  other 
commodities for which Codex Alimentarius has established CXLs in 2012 are covered by the risk 
assessment performed by EFSA in 2012 since the CXLs correspond to the import tolerances proposed 
by EFSA (taking into account the different residue definitions). Considering the reservation of the EU 
delegation, the CXLs for pulses is not taken into account; instead the previously established individual 
CXLs beans (dry), peas (dry) and soya bean (dry) are included in the dietary exposure calculation. The 
details of the authorised GAPs for saflufenacil, for which import tolerances were requested, can be 
found in the previously issued EFSA opinion (Appendix A of EFSA, 2012a). They are identical to the 
critical GAPs assessed by JMPR for deriving the CXL proposals (FAO, 2011b, 2012).  
Table 3-1:  Overview of the proposed/existing MRLs derived by EFSA, JMPR and USA 
Code 
number 
Commodity  Proposed EU 
MRL (mg/kg)
(1) 
Critical GAP for 
EU MRL 
proposal 
CXL 
(mg/kg)
(2) 
US tolerance 
(mg/kg)
(3) 
0110010  Grapefruit   0.03*  USA  0.01  0.03 
0110020  Oranges  0.03*  USA  0.01  0.03 
0110030  Lemons  0.03*  USA  0.01  0.03 
  Other citrus fruit  No  MRL 
requested 
N/A  0.01  0.03 
0120010  Almonds  0.03*  USA  0.01  0.03 
0120080  Pecans  0.03*  USA  0.01  0.03 
  Other tree nuts  No  MRL 
requested 
N/A  0.01  0.03 
0130010  Apples  0.03*  USA  0.01  0.03 
0130020  Pears  0.03*  USA  0.01  0.03 
  Other pome fruit  No  MRL 
requested 
N/A  0.01  0.03 
0140020  Cherries  0.03*  USA  0.01  0.03 
0140030  Peaches  0.03*  USA  0.01  0.03 
0140040  Plums  0.03*  USA  0.01  0.03 
  Other stone fruit  No  MRL 
requested 
N/A  0.01  0.03 
0151000  Table  and  wine 
grapes  
0.03*  USA  0.01  0.03 
0163020  Banana   0.03*
  Costa  Rica, 
Ecuador 
0.01  No MRL 
0163030  Mangoes  0.03*
  Brazil  No CXL  No MRL 
0234000  Sweet corn   0.03*  USA  0.01  0.03 Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Code 
number 
Commodity  Proposed EU 
MRL (mg/kg)
(1) 
Critical GAP for 
EU MRL 
proposal 
CXL 
(mg/kg)
(2) 
US tolerance 
(mg/kg)
(3) 
0260000  Legume  vegetables 
(fresh) 
0.03*  USA  0.01  (peas 
with  and 
without  pods, 
soya  beans 
(immature 
seeds)) 
0.03 
0300010  Dry beans  0.5
  USA  0.3  0.3 
0300030  Dry peas  0.1
  USA  0.05 (proposed 
by  JMPR  in 
2011)  
0.3  (proposed 
by  JMPR  in 
2012,  EU 
reservation) 
0.3 
  Other pulses  No  MRL 
requested 
N/A  0.3  (proposed 
by  JMPR  in 
2012,  EU 
reservation) 
0.3 
0401070  Soya bean  0.1
  USA  0.07 (proposed 
by  JMPR  in 
2011)  
0.3  (proposed 
by  JMPR  in 
2012,  EU 
reservation)  
0.1 
0401090  Cotton seed  0.3
  USA  0.2  0.2 
0401050  Sunflower seed   1.0  USA  0.7  1.0 
0401060  Rape seed  No  MRL 
requested 
N/A  0.6
(5)  0.45 
0500000 
(except 
0500020) 
Cereals  (except 
buckwheat) 
0.03*  USA  0.01  0.03 
0900020  Sugarcane  0.03*  Brazil  No CXL  No MRL 
0211000  Potatoes  No  proposal 
(EFSA,  2012a) 
0.03*  (see 
section 2.1.2) 
Brazil  No CXL  No MRL 
0620000  Coffee beans  No  proposal 
(EFSA, 2012a) 
0.03*  (see 
section 2.1.2) 
Costa  Rica, 
Ecuador 
0.01  No MRL 
1011010 
1011020 
1011040 
Swine meat 
Swine fat 
Swine kidney 
0.01* 
0.01* 
0.01* 
N/A  0.01 
0.01 
0.3
(4) 
No MRL 
1011030  Swine liver  0.3  N/A  0.3
(4)  No MRL Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Code 
number 
Commodity  Proposed EU 
MRL (mg/kg)
(1) 
Critical GAP for 
EU MRL 
proposal 
CXL 
(mg/kg)
(2) 
US tolerance 
(mg/kg)
(3) 
1012010 
1013010 
1014010 
Bovine meat 
Sheep meat 
Goat meat 
0.01*  N/A  0.01  No MRL 
1012020 
1013020 
1014010 
Bovine fat 
Sheep fat 
Goat fat 
0.01*  N/A  0.01  No MRL 
1012030 
1013030 
1014030 
Bovine liver 
Sheep liver 
Goat liver 
0.6  N/A  0.3
(4) 
 
No MRL 
1012040 
1013040 
1014040 
Bovine kidney 
Sheep kidney 
Goat kidney 
0.02  N/A  No MRL 
1016000  Poultry  meat,  fat, 
liver,  kidney,  edible 
offal 
0.01*  N/A  No proposal  No MRL 
1020000  Milk  0.01*  N/A  0.01  No MRL 
1030000  Eggs  0.01*  N/A  No proposal  No MRL 
(1): MRL proposed by EFSA in the reasoned opinion issued in 2012 (EFSA, 2012a): EU enforcement residue definition for 
commodities  of  plant  origin:  the  sum  of  saflufenacil,  M800H11  and  M800H35,  expressed  as  saflufenacil;  EU 
enforcement residue definition for commodities of animal origin: saflufenacil. 
(2): CXLs adopted in 2012, including the proposal discussed in CCPR meeting 2013 as regards pulses and revocation of 
CXLs for peas (dry) and soya beans. Codex enforcement residue definition for commodities of plant and animal origin: 
saflufenacil. 
(3): US residue definition: sum of saflufenacil, M800H11 and M800H35, expressed as saflufenacil. 
(4): CXL for edible offal-mammalian. 
(5): As the Codex residue definition does not contain the two metabolites, the CXL should be recalculated. However, since in 
the metabolism studies in soya beans representative for the GAP (late application, desiccation use) these metabolites 
were not identified, the CXL can be transferred to the EU legislation without recalculation. It is noted that in the USA 
MRL is set at 0.45 mg/kg for the RD comparable to the EU RD for the GAP assessed by JMPR. 
3.1.  Results of updated consumer risk assessment for saflufenacil  
The input values for the long-term and short term exposure assessment for the commodities mentioned 
are summarised in the following table (Table 3-2). 
Table 3-2:  Input values for the updated consumer dietary exposure assessment (including the input 
values for the CXLs adopted in 2012) 
Commodity  Chronic exposure assessment  Acute exposure assessment 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Risk  assessment  residue  definition  for  plant  commodities:  the  sum  of  saflufenacil,  M800H11  and 
M800H35, expressed as saflufenacil 
All citrus fruit  0.03  Median residue 
(EFSA, 2012a), 
extrapolated to all 
citrus 
0.03  Highest residue 
(EFSA, 2012a), 
extrapolated to all 
citrus Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Commodity  Chronic exposure assessment  Acute exposure assessment 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
All pome fruit  0.03  Median residue 
(EFSA, 2012a), 
extrapolated to all 
pome fruit 
0.03  Highest residue 
(EFSA, 2012a), 
extrapolated to all 
pome fruit 
All tree nuts  0.03  Median residue 
(EFSA, 2012a), 
extrapolated to all 
tree nuts 
0.03  Highest residue 
(EFSA, 2012a), 
extrapolated to all 
tree nuts 
All stone fruit  0.03  Median residue 
(EFSA, 2012a), 
extrapolated to all 
stone fruit 
0.03  Highest residue 
(EFSA, 2012a), 
extrapolated to all 
stone fruit 
Grapes  0.03  Median residue 
(EFSA, 2012a) 
0.03  Highest residue 
(EFSA, 2012a) 
Banana  0.03  Median residue 
(EFSA, 2012a) 
0.03  Highest residue 
(EFSA, 2012a) 
Mango  0.011  Median residue 
(EFSA, 2012a) 
0.02  Highest residue 
(EFSA, 2012a) 
Potatoes  0.03  Median residue (see 
section 2.1.2) 
0.03  Highest residue (see 
section 2.1.2) 
Sweet corn  0.03  Median residue 
(EFSA, 2012a) 
0.03  Median residue 
(EFSA, 2012a) 
Peas  (without  pods),  beans 
(without  pods),  peas  (with 
pods),  beans  (with  pods), 
lentils (fresh) 
0.03  Median residue 
(EFSA, 2012a) 
0.03  Highest residue 
(EFSA, 2012a) 
Dry beans  0.03  Median residue (dry 
beans) (EFSA, 
2012a) 
0.03  Median residue (dry 
beans) (EFSA, 
2012a) 
Dry peas  0.03  Median residue (dry 
beans) (EFSA, 
2012a) 
0.03  Median residue (dry 
beans) (EFSA, 
2012a) 
Rape seed  0.6  CXL (FAO, 2011)  0.6  CXL (FAO, 2011) 
Soybean  0.03  Median residue (dry 
beans)  
(EFSA, 2012a) 
0.03  Median residue (dry 
beans)  
(EFSA, 2012a) 
Sunflower  0.22  Median residue 
(EFSA, 2012a) 
0.22  Median residue 
(EFSA, 2012a) 
Cotton  0.05  Median residue 
(EFSA, 2012a) 
0.05  Median residue 
(EFSA, 2012a) 
Wheat, rice, barley, rye, oat, 
maize, sorghum 
0.03  Median residue 
(EFSA, 2012a) 
0.03  Median residue 
(EFSA, 2012a) 
Sugarcane  0.03  Median residue 
(EFSA, 2012a) 
0.03  Highest residue 
(EFSA, 2012a) 
Coffee beans  0.03  Median residue (see 
section 2.1.2) 
0.03  Median residue (see 
section 2.1.2) Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Commodity  Chronic exposure assessment  Acute exposure assessment 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Other  food  commodities  of 
plant origin 
0.03  LOQ  No relevant for acute exposure 
assessment 
Risk assessment residue definition for animal commodities: saflufenacil 
Pig liver  0.20  Median residue 
(EFSA, 2012a) 
0.25  Highest residue 
(EFSA, 2012a) 
Pig kidney, meat, fat  0.01  Median residue 
(EFSA, 2012a) 
0.01  Highest residue 
(EFSA, 2012a) 
Liver of bovine, sheep, goat  0.5  Median residue 
(EFSA, 2012a) 
0.58  Highest residue 
(EFSA, 2012a) 
Kidney  of  bovine,  sheep, 
goat 
0.015  Median residue 
(EFSA, 2012a) 
0.015  Highest residue 
(EFSA, 2012a) 
Meat,  fat  of  bovine,  sheep, 
goat 
0.01  Median residue 
(EFSA, 2012a) 
0.01  Highest residue 
(EFSA, 2012a) 
Poultry  meat,  fat,  kidney, 
liver 
0.01  Median residue 
(EFSA, 2012a) 
0.01  Highest residue 
(EFSA, 2012a) 
Eggs  0.01  Median residue 
(EFSA, 2012a) 
0.01  Highest residue 
(EFSA, 2012a) 
Milk  0.01  Median residue 
(EFSA, 2012a) 
0.01  Median residue 
(EFSA, 2012a) 
Other  commodities  of 
animal origin 
0.01  LOQ  Not relevant for acute exposure 
assessment 
 
EFSA calculated the chronic and acute exposure according to the internationally agreed methodology 
using the consumption data included in the EFSA PRIMo rev. 2, and compared the resulting exposure 
with the ADI and ARfD, derived in the previous opinion on saflufenacil (i.e. ADI of 0.046 mg/kg 
body weight per day, ARfD of 0.05 mg/kg body weight). In this updated risk assessment no consumer 
concerns were identified: the long-term (chronic) exposure accounted for a maximum of 3.2 % of the 
ADI (UK toddler) while the short-term (acute) exposure did not exceed 10 % of the ARfD for any of 
the commodities for which MRL proposals were derived (maximum for bovine liver: 9.4% of the 
ARfD).  On  the  basis  of  this  updat ed  dietary  exposure  assessment  for  saflufenacil  (including 
metabolites M800H11 and M800H35), EFSA concludes that the CXLs adopted in 2012 do not pose a 
consumer health concern. Compared with the results of the exposure assessment performed in the 
previous reasoned opinion (EFSA, 2012a) no significant changes with regard the expected dietary 
exposure of European consumers are observed. More detailed results of the exposure calculation can 
be found in Appendix B.  
4.  Exposure assessment/risk assessment TFA 
In  its  mandate,  the  European  Commission  asked  EFSA  to  assess  the  consumer  exposure  to  the 
metabolite trifluoroacetic acid from all sources, taking into account the principles for assessment as 
described in the recent EFSA Scientific Opinion on the Evaluation of the Toxicological Relevance of 
Pesticides  Metabolites  for  Dietary  Risk  Assessment  (EFSA,  2012b).  In  this  opinion  EFSA  has 
elaborated  an  approach  to  evaluate  the  toxicological  relevance  of  metabolites  and  degradates  of 
pesticide  active  substances  in  dietary  risk  assessment  for  which  limited  information  on  the 
toxicological properties is available and for which the derivation of toxicological reference values is 
not possible. As specific toxicological studies for TFA were made available after the mandate was 
submitted  to  EFSA  which  allowed  to  derive  a  tentative  ADI/ARfD  (see  section  1),  most  of  the Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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recommendations of this opinion are of no relevance, except some of the recommendations of chapter 
8  supported  by  Appendix  D  and  E,  which  elaborate  how  results  of  metabolism  studies  can  be 
extrapolated by using conversion factors to perform exposure assessments for metabolites for which 
no results of supervised field trials are available.  
4.1.  Background information on TFA 
TFA is very soluble in water and has a low octanol/water partition coefficient (log Pow = -0.2 at pH7, 
20°C) (BASF, 2011), which indicates that it has a low potential for bioaccumulation. TFA is a strong 
organic  acid  with  a  pKa  of  0.23  (BASF,  2011).  Thus,  under  physiological  and  environmental 
conditions, TFA is occurring as salts. TFA is highly stable and not easily degraded chemically or by 
phototlysis in the natural environment.  
TFA can accumulate in plants via roots uptake of water; it was shown that TFA is transported in the 
xylem through the stem and accumulated in leaves (Rollins et al., 1989).  
The chemical structure of TFA is reported below.  
 
Mol. weight: 114.02 
4.2.  Identification of possible sources of exposure to TFA  
To address the request of the European Commission EFSA structured this section as follows:  
  Estimation of TFA concentrations resulting from the use of saflufenacil, taking into account 
the notified uses on the crops for which MRLs were requested/CXLs were derived (section 
4.1.2); 
  Identification  of  other  pesticides  as  possible  sources  of  TFA;  estimation  of  TFA 
concentrations related to these pesticides in food (section 4.2.1);  
  Identification of other sources of TFA exposure (environmental contaminations); estimation of 
TFA concentrations relevant for dietary exposure from other sources (section 4.2.2);  
  Estimation of the overall exposure to TFA resulting from all sources (section 4.2.3). 
4.2.1.  Estimation of TFA concentrations resulting from the use of saflufenacil  
4.2.1.1.  Primary crop metabolism  
The  metabolism  of  saflufenacil  in  primary  crops  (tomatoes  and  in  glyphosate  tolerant  maize  and 
soybean) was evaluated by the EMS (UK, 2011a) and is described in detail in the previously issued 
reasoned opinion of EFSA (EFSA, 2012a) as well as in the JMPR evaluation (FAO, 2011). Only the 
metabolism studies using 
14C-uracyl-labelled saflufenacil allow tracing the formation of TFA.  
In maize, TFA (M800H29) was the predominant constituent of the methanol extracts of all matrices 
investigated  (30.5%  to  88%  TRR,  in  grain  it  accounted  for  0.004  mg/kg).  Since  the  potentially 
corresponding [
14C]phenyl-labelled metabolites as counter parts of M800H29 were not detected at 
adequate quantities, JMPR explained the occurrence of TFA by the uptake of this metabolite or a 
respective precursor molecule from the soil (FAO, 2011). Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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In soya beans after pre-emergence application to the soil surface, TFA was the major compound 
identified (65.4 %TRR (beans) to 85.2%TRR (forage)). In the metabolism study investigating the 
desiccation use (7 before harvest), no TFA was identified (FAO, 2011).  
In tomatoes TFA was also found being the predominant constituent of the methanol extracts of plant 
matrices investigated (48.6% TRR (in fruit) to 82.2%TRR (in tomato plant)). The occurrence of TFA 
was explained by the uptake of this metabolite or of a respective precursor molecule from the soil 
(FAO, 2011).  
On the basis of the submitted metabolism studies EFSA concluded that in addition to the residue 
definition which comprises saflufenacil, M800H11 and M800H35 also TFA should be considered for 
consumer risk assessment (EFSA, 2012a).   
It is noted that in the evaluation of JMPR, TFA was also identified as a major metabolite in maize, 
soybean and tomatoes. Its occurrence was explained by the uptake of the compound or a respective 
precursor molecule from soil. TFA was also one of the major photoproducts formed in aquatic systems 
and  a  major  metabolite  in  rotational  crop  studies  (FAO,  2011).  However,  TFA  was  not  further 
considered to be included in a residue definition.  
In order to estimate the concentrations of TFA relevant for a comprehensive exposure assessment, the 
results for saflufenacil and TFA obtained in metabolism studies are summarised in Table 4-1. These 
concentrations are used to calculate conversion factors (last column) which can, in accordance with 
the  recommendations  of  the  Scientific  Opinion  on  the  Toxicological  Relevance  of  Pesticide 
Metabolites for  Dietary  Risk  Assessment  (EFSA, 2012b),  be  used  under  certain circumstances to 
estimate the concentration of the metabolite for the exposure assessment of toxicologically relevant 
metabolites.  
Table 4-1: Summary  of  metabolism  studies  with 
14C-uracyl-labelled  saflufenacil  regarding  the 
concentration of parent saflufenacil and TFA 
Crop group  Crop  Application 
rate (kg 
as/ha) 
No of 
applications 
DAT  Saflufenacil/TFA
1) 
(mg/kg) 
Conversion factor 
saflufenacil to 
TFA
2) 
Cereals (pre-
emergence, 
treatment  of 
soil  surface 
after  crop 
sowing) 
Corn 
(forage) 
0.2  1  42 DAT  <0.0005/0.006  N/A 
(>12) 
Corn 
(forage) 
102 DAT  n.d/0.026  N/A 
(>52) 
Corn 
(husks) 
133 DAT  n.d./0.045  N/A 
(>90) 
Corn (cob)  133 DAT  n.d./0.01  N/A 
(>20) 
Corn 
(grain) 
133 DAT  n.d./0.004  N/A 
(>8) 
Corn 
(straw) 
133 DAT  n.d./0.098  N/A 
(>196) 
Pulses  and 
oilseeds 
(pre-
emergence, 
treatment  of 
soil  surface 
after  crop 
sowing) 
Soya  bean 
(forage) 
0.15  1  39 DAT  0.015/0.074  4.9 
Soya  bean 
(bean) 
95 DAT  0.002/0.033  16.5 
Soya  bean 
(pod) 
95 DAT  n.d./0.351  N/A  
(>702) 
 
Soya  bean 
(straw) 
95 DAT  0.034/0.187  5.5 
Pulses  and 
oilseeds 
(pre-harvest 
Soya  bean 
(stem) 
0.1  1  7 DAT  0.306/n.r.  N/A 
Soya  bean  7 DAT  1.420/n.r.  N/A Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Crop group  Crop  Application 
rate (kg 
as/ha) 
No of 
applications 
DAT  Saflufenacil/TFA
1) 
(mg/kg) 
Conversion factor 
saflufenacil to 
TFA
2) 
desiccant 
use) 
(pod) 
Soya  bean 
(seed) 
7 DAT  0.011/n.r.  N/A 
Soya  bean 
(leaves) 
7 DAT  11.423/n.r.  N/A 
Fruits  and 
fruiting 
vegetables 
(pre-
emergence, 
treatment  of 
soil  surface 
before 
transplanting 
if  tomato 
plants 
Tomatoes 
(growth 
stage 
62/63) 
0.1  1  68 DAT  0.006/0.025  4.2 
Tomatoes 
(plants  at 
harvest) 
113 DAT  0.012/0.016  1.3 
Tomatoes 
(fruit) 
113 DAT  n.d./0.004  N/A 
(>8) 
n.d. not detected, <0.0005 mg/kg.  
n.r. not reported 
N/A: not applicable 
1)  The results for TFA are expressed as TFA, considering the molecular weight of TFA.  
2)  The conversion factor is calculated by dividing the concentration of TFA by the concentration of saflufenacil. In case the 
residue concentration of saflufenacil was below the detection limit (<0.005 or n.d.), an indicative conversion factor 
(reported in brackets) was calculated assuming a saflufenacil concentration of 0.005 mg/kg. 
 
Considering the wide range of conversion factors, the limited number of crops tested in metabolism 
studies and low residue concentrations of parent compound in the analysed matrices - in some cases 
below the detection limit -, the use of conversion factors to estimate the TFA residue concentration is 
introducing a high uncertainty in the dietary risk assessment. In its previous opinion EFSA proposed to 
use the conversion factor of 8 for cereals and fruits and fruiting vegetables and 16.5 for pulses and oil 
seeds. For crops where a desiccation use was reported, no significant TFA residues resulting form the 
primary crop treatment were expected and therefore no conversion factor was derived (EFSA, 2012a).  
Comparing the derived theoretical TFA input values for dietary exposure assessment (Table 4-3 of 
EFSA, 2012a) with the measured TFA residue concentration in metabolism studies, the approach used 
seemed to be highly conservative (e.g. TFA concentration in tomato (fruit) in metabolism study is 
0.004 mg/kg while the input value for all fruit crops was calculated to be 0.08 mg/kg (0.01 mg/kg * 
CF (8), which is 20 times higher). In the UK position paper this discrepancy was addressed by re-
evaluating the raw data of residue trials for citrus, tree nuts, pome fruits, stone fruits, grapes, banana, 
mango and sweet corn as regards the residue results for saflufenacil (United Kingdom, 2012). The re-
evaluation demonstrated that for the majority of crops the residues were below the limit of detection 
(LOD) of 0.002 mg/kg. The results reported in the UK position paper are summarised in Table 4-2 
below.  
Table 4-2:  Results of re-evaluated residue trials as regards the residue concentration of saflufenacil 
Commodity  Median residue 
concentration 
(mg/kg) 
Highest residue 
concentration 
(mg/kg) 
Orange  n.d.  0.009 
Lemon  n.d.  n.d. 
Grapefruit  n.d.  0.010 
Almonds  n.d.  0.003 Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Commodity  Median residue 
concentration 
(mg/kg) 
Highest residue 
concentration 
(mg/kg) 
Pecans  n.d.  n.d. 
Apples  n.d.  n.d. 
Pears  n.d.  n.d. 
Peaches  n.d.  n.d. 
Cherries  n.d.  n.d. 
Plums  n.d.  0.004 
Grapes  n.d.  0.002 
Banana  n.d.  n.d. 
Mango  n.d.  n.d. 
Sweet corn  n.d.  n.d. 
n.d. not detected, limit of detection: 0.002 mg/kg 
 
EFSA acknowledges this additional information which confirms that the approach used by EFSA in 
the previously issued reasoned opinion to estimate the concentrations of TFA was very conservative. 
Considering that the limit of quantification is by definition the lowest concentration which can be 
quantified  reliably,  EFSA  is  reluctant  to  follow  the  proposal  of  the  applicant  to  use  the  limit  of 
detection (a concentration level which can be detected with acceptable certainty, but is not quantifiable 
accurately), in the exposure assessment as the estimate for the residue concentration of saflufenacil. 
Noting  the  uncertainties,  EFSA  proposes  to  stick  to  the  approach  used  in  the  framework  of  the 
previous EFSA opinion. However, a sensitivity analysis should be performed which allows to estimate 
the impact of the conservative approach, using the LOQ of 0.01 mg/kg for the crops mentioned
5 in 
Table 4-2 instead of the LOD of 0.002 mg/kg as proposed by the applicant.  
4.2.1.2.  Rotational crop metabolism 
TFA residues may occur in crops that are grown in crop rotation on fields that were previously treated 
with saflufenacil. The available rotational crop metabolism studies on lettuce, white radish and spring 
wheat which are described in more detail in the previously issued reasoned opinion (EFSA, 2012a) 
and in the JMPR evaluation (FAO, 2011) give an indication of the transfer of TFA to the different 
crop parts.  
For  wheat  grain  grown  on  fields  previously  treated  with  saflufenacil  at  an  application  rate  not 
exceeding  the  dose rates reported  in the  relevant  GAPs,  the TFA  residue concentrations in  grain 
ranged from 0.01 mg/kg to 0.074 mg/kg. JMPR noted that since [
14C] phenyl-labelled metabolites as 
counter parts have not been detected at corresponding quantities, the occurrence of TFA could be 
explained by uptake of this metabolite or a respective precursor molecule from the soil (FAO, 2011).  
In  lettuce  heads  and  other  leafy  crop  parts  (white  radish  tops,  wheat  forage)  the  TFA  residue 
concentrations ranged from 0.003 mg/kg to 0.019 mg/kg.  
For  root  crops  (radish  roots),  the  TFA  concentrations  were  reported  in  concentrations  between 
0.002 mg/kg and 0.007 mg/kg.  
In Table 4-3 the results of the metabolism studies in rotational crops are summarised, focussing on the 
residue concentrations of parent saflufenacil and TFA. 
                                                       
5 The data will be extrapolated (e.g. data for orange, lemon and grapefruit can be extrapolated to the whole group of citrus 
fruit). Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Table 4-3:  Results of metabolism studies in rotational crops  
 
Crop  Application 
rate (kg 
as/ha) 
No of 
applications 
PBI  Saflufenacil (mg/kg)  TFA 
1)  
(mg/kg) 
Lettuce heads  0.15  1  30  0.004  0.017 
120  0.001  0.019 
365  n.a.  n.a. 
White radish roots  0.15  1  30  0.000  0.007 
120  0.000  0.002 
365  n.a.  n.a. 
White radish tops  0.15  1  30  0.002  0.0034 
120  0.001  0.009 
365  0.001  0.018 
Wheat forage   0.15  1  30  0.001  0.037 
120  0.000  0.011 
365  0.000  0.003 
Wheat straw   0.15  1  30  0.000  0.055 
120  0.000  0.034 
365  0.000  0.060 
Wheat chaff  0.15  1  30  0.000  0.322 
120  0.000  0.122 
365  0.000  0.082 
Wheat grain  0.15  1  30  0.000  0.074 
120  0.000  0.017 
365  0.000  0.01 
n.a. not analysed 
1): The results for TFA were re-calculated in consideration of the molecular mass of TFA. 
 
Considering the available data, EFSA tried to derive indicative concentrations of TFA in food (Table 
4-3) resulting from the use of saflufenacil. As these data are based on metabolism studies and do not 
reflect actual GAPs, they are affected by a high level of uncertainty. It is also noted that the study 
design reflects the worst case conditions and the application rate is slightly higher than in the GAPs 
notified. Thus, these TFA concentrations are considered to be sufficiently conservative. Taking all 
these uncertainties, EFSA is of the opinion that the data can be used to estimate the order of magnitude 
of TFA concentrations resulting in food crops and were therefore considered in the derivation of the 
input values for the dietary exposure assessment (See Table 4-6). 
4.2.1.3.  Animal metabolism 
Metabolism  studies  in  rats  performed  to  investigate  the  absorption,  distribution,  metabolism  and 
excretion of saflufenacil did not give any indications that metabolite M800H29 (TFA) is formed in 
rats exposed to saflufenacil (JMPR, 2011). Also in livestock metabolism studies with goats and laying 
hen no TFA was identified (FAO, 2011). Thus, food of animal origin derived from animals exposed to 
saflufenacil is not expected to be a significant source for exposure to TFA.  
No information is available whether and to what extent TFA residues might occur in food of animal 
origin in significant concentrations if livestock is exposed to TFA via feed. This lack of information is 
considered to be a source of uncertainty in the exposure assessment.  
4.2.2.  Estimation of the dietary exposure to TFA resulting from the use of other pesticides  
TFA  is  a  plant  metabolite  which  can  result  from  a  wide  range  of  pesticides  which  contain  the 
trifluoromethyl group. Theoretically, all pesticides containing this common moiety have the potential 
to  produce  TFA  as  a  degradation  product.  In  order  to  identify  other  possible  sources  for  TFA Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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exposure, EFSA screened the structural formula of pesticides (Compendium of Pesticide Common 
Names
6) with view to structural features of the molecule which may lead to the formation of TFA (i.e. 
trifluoromethyl-group). In total  ca. 140 active substances were identified, 39 thereof are currently 
approved under Regulation (EC) No 1107/2009, for 5 of these substances the peer review is  ongoing. 
In Appendix C the results of the screening for approved/pending and non-approved substances are 
listed along with further evidence on the formation of TFA relevant for dietary consumer exposure. In 
particular,  the  Draft  Assessment  Reports,  EFSA  conclusions  and  EFSA  reasoned  opinions  were 
examined if TFA was explicitly mentioned in primary or rotational crop metabolism or in livestock 
metabolism.  
Considering the available data, EFSA tried to derive indicative concentrations of TFA in food (Table 
4-4) resulting from the use of other pesticides. As these data are based on metabolism studies and do 
not reflect actual GAPs, they are affected by a high level of uncertainty. However, they can be used to 
estimate the order of magnitude of TFA concentrations resulting from the use of other pesticides and 
were therefore considered in the derivation of the input values for the dietary exposure assessment 
(See Table 4-6).   
Table 4-4:  Indicative TFA concentrations quantified in primary crop metabolism and rotational 
crop metabolism studies  
Study  Crop  TFA
  
(mg/kg) 
Comment 
Fluazinam,  
primary  crop 
metabolism study 
Potatoes (tuber)  <0.00025  Insignificant residue concentration, not 
relevant for dietary exposure 
assessment.  
Apples  0.0058  To be considered in exposure 
assessment for apples and grapes (crops 
where the fluazinam MRLs >LOQ).  
Fluazinam, rotational 
crop  metabolism 
study 
Lettuce  0.068  Extrapolation to all leafy crops, fruiting 
vegetables, cucurbits, brassica 
vegetables, legume vegetables, stem 
vegetables. 
Barley grain  0.045  Extrapolation to all cereals 
Carrots  0.014  Extrapolation to all root and tuber 
vegetables and bulb vegetables  
Trifloxystrobin, 
rotational crop study 
 
White radish roots  0.016  Results affected by uncertainties, but 
indicative result to be extrapolated to 
root and tuber vegetables and bulb 
vegetables   
Wheat  0.016  Indicative result affected by 
uncertainties; to be extrapolated to all 
cereals.  
 
4.2.3.  Estimation  of  the  dietary  exposure  to  TFA  resulting  from  environmental 
contaminations or unknown sources 
Trifluoroacetates, the salts of TFA, are substances which are found ubiquitous in all environmental 
compartments (air, precipitation, surface water, plants, soil). So far, no natural sources were identified. 
Like other trihalogenated acetates trifluoroacetates are persistent. It is assumed that these compounds 
originate  from  anthropogenic  sources  via  degradation  of  organic  compounds  containing  a 
trifluoromethyl-group such as hydro(chloro)fluorocarbons (HFC/HCFCs). These substances are used 
as  substitutes  for  chlorofluorocarbons  (CFCs),  which  are  known  as  causing  undesirable  ozone-
damaging effects (Christoph, 2002).  
                                                       
6 http://www.alanwood.net/pesticides/index.html Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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In the position paper of the applicant (BASF, 2011) results of TFA analysis in locally purchased food 
were reported. The samples were analysed with a method having a LOQ of 0.01 mg/kg. The data were 
generated to estimate the background levels of TFA in food where the treatment history is unknown 
(random monitoring). The results of these analysis are summarised in Table 4-5. Further details can be 
found in the position paper of BASF.  
Table 4-5:  TFA residues in store bought crop commodities 
Crop  TFA concentration 
(mg/kg) 
Comment 
Orange  0.012 to 0.021   
Apple  all <0.01  in individual samples traces of TFA 
were present (>LOD 0.001 mg/kg) 
Peach  all <0.01  in individual samples traces of TFA 
were present (>LOD 0.001 mg/kg) 
Cherries  all <0.01  in individual samples traces of TFA 
were present (>LOD 0.001 mg/kg) 
Almonds  0.02 to 0.072   
Table grapes  all <0.01  in individual samples traces of TFA 
were present (>LOD 0.001 mg/kg) 
Soya beans  <0.01 to 0.16   
 
EFSA performed a literature search with a view to identify other sources of information which can be 
used to estimate the dietary exposure for TFA. The search strategy and the summary findings are 
reported in Appendix D. The literature search did not reveal additional data on TFA concentrations in 
food which can be directly used for the dietary exposure assessment.  However, the literature search 
confirmed the ubiquitous occurrence of TFA in the environment which might contribute indirectly to 
the overall dietary exposure via drinking water or residues of TFA in food crops via soil uptake; in 
addition, consumers may be exposed through other exposure routes (e.g. inhalative). The reported 
TFA concentration in air ranged from 10 to 120 pg/m³ (Frank et al, 1995; Klein, 1997). Rain water 
was found to contain TFA concentrations between 10 and 400 ng/L (mean value 80ng/L) (Klein, 1997, 
Jordan, 1999, Von Sydow et al, 1996). In German rivers the TFA was found in concentrations between 
60  and  630  ng/L,  while  in  lake  water  from  Germany,  Ireland,  Israel  and  South  Africa  TFA 
concentrations ranged from <10 to 200 ng/L (Jordan, 1999). In spruce needles the TFA concentrations 
differed widely (between 7 and 1925 µg/kg), the highest concentrations were found in sites  close to 
industrial locations (Christoph, 2002).  
The literature search provided evidence of TFA exposure resulting from the use of halothane or other 
structurally comparable anaesthetics (e.g. isoflurane, desflurane, sevoflurane) which are metabolised 
in humans to TFA. However, this type of exposure is beyond the mandate and was therefore not 
further evaluated.  
4.3.  Overall  expected  dietary  consumer  exposure  to  TFA,  resulting  from  all  sources  of 
exposure 
In the current mandate, European Commission asked EFSA to assess the consumer exposure to the 
metabolite trifluoroacetic acid (TFA) resulting from all sources. Thus, the long-term and short-term 
exposure is calculated taking into account the following information:  
  TFA residues in primary crops resulting from the use of saflufenacil: Since no supervised 
residue trials are available quantifying the actual TFA residues in treated crops, EFSA used 
the results of metabolism studies to estimate the TFA concentrations that might be present on 
crops treated with saflufenacil. The TFA concentration is derived by using a CF (see Section Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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4.2.1.1). Since there is some evidence that in particular for fruit crops this approach is very 
conservative, EFSA performed a sensitivity analysis where the input values derived for fruit 
crops are replaced by a less conservative estimate (only for long-term exposure assessment);  
  TFA residues in rotational crops grown on fields previously treated with saflufenacil (see 
Section 4.2.1.2); 
  TFA  residues  resulting  from  other  pesticides  that  are  metabolised  to  TFA  and  where 
measurable  TFA  concentrations  are  expected  in  primary  or  rotational  crops  (see  Section 
4.2.2). The results of metabolism studies in rotational crops were extrapolated to similar crops 
that can be grown in crop rotation.  
  TFA residues resulting in food from environmental contaminations (see Section 4.2.3). 
In the exposure assessment EFSA did not take into account other sources of exposure (e.g. inhalation 
or exposure through pharmacological treatment like anaesthetics which are metabolised to TFA) and 
the exposure through drinking water which is not included in the agreed European model for exposure 
assessment (EFSA PRIMo). Dietary exposure thorough drinking water is expected to be insignificant
7.  
It is noted that TFA is registered under the REACH Regulation
8 in a tonnage band of 1000 to 10.000 
tons per annum. Occupational or environmental exposures associated to these uses or t hose of other 
substances producing TFA as metabolite or degradation product are not covered in this opinion. 
Since the input values derived for the comprehensive exposure assessment are subject to a high level 
of uncertainties, the results of the exposure  assessment are less accurate compared with standard 
exposure assessments.  
In Table 4-6 the selected input values used for the dietary exposure calculation are  outlined. Since 
EFSA selected very conservative estimates, the same input values can be used for  chronic and acute 
exposure assessment. The consumer risk assessment was performed with revision 2 of the EFSA 
Pesticide Residues Intake Model (PRIMo) (EFSA, 2007). It was noted that the TFA exposure 
calculation is affected by a high level of uncertainties and therefore the results should be considered as 
indicative, but they should allow estimating the order of magnitude of exposure.  
Table 4-6: Input values for the comprehensive dietary exposure assessment for trifluoroacetic acid.  
                                                       
7 Consumption of 2 L of water containing 630 ng/L (highest concentration reported for European surface water) by an adult 
of 60 kg body weight corresponds to 0.04 % of the ADI derived for TFA.  
8 Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 con cerning the 
Registration, Evaluation, Authorisation and Restric tion of Chemicals (REACH), establishing a European Chemicals 
Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation 
(EC)  No  1488/94  as  well  as  Council  Directive   76/769/EEC and  Commission  Directives  91/155/EEC, 93/67/EEC, 
93/105/EC and 2000/21/EC. OJ L 396 of 30.12.2006, p. 1-848. Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Commodity  Chronic exposure assessment  Acute exposure assessment 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Risk assessment residue definition: Trifluoroacetic acid (TFA) 
Citrus fruit  0.081)  Median  residue 
(saflufenacil)  *  CF 
(8),  extrapolation  of 
data  from  oranges, 
lemons,  grapefruit  to 
all citrus (See table 4-
3 of EFSA, 2012a) 
0.08  Max.  residue 
(saflufenacil)  *  CF 
(8), extrapolation of 
data  from  oranges, 
lemons,  grapefruit 
to  all  citrus  (See 
table 4-3 of EFSA, 
2012a) 
Pome fruit  0.081)  Median  residue 
(saflufenacil)  *  CF 
(8),  extrapolation  of 
data from apples and 
pears to all pome fruit 
(See  table  4-3  of 
EFSA, 2012a) 
0.08  Max.  residue 
(saflufenacil)  *  CF 
(8), extrapolation of 
data  from  apples 
and  pears  to  all 
pome  fruit  (See 
table 4-3 of EFSA, 
2012a) 
Tree nuts  0.081)  Median  residue 
(saflufenacil)  *  CF 
(8),  extrapolation  of 
data  from  almonds 
and pecan to all tree 
nuts(See table 4-3 of 
EFSA, 2012a) 
0.08  Max.  residue 
(saflufenacil)  *  CF 
(8), extrapolation of 
data  from  almonds 
and pecan to all tree 
nuts(See  table  4-3 
of EFSA, 2012a) 
Stone fruit  0.081)  Median  residue 
(saflufenacil)  *  CF 
(8),  extrapolation  of 
data  from  cherries, 
peaches and plums to 
all  stone  fruit(See 
table  4-3  of  EFSA, 
2012a) 
0.08  Max.  residue 
(saflufenacil)  *  CF 
(8), extrapolation of 
data  from  cherries, 
peaches  and  plums 
to  all  stone 
fruit(See  table  4-3 
of EFSA, 2012a) 
Grapes  0.081)  Median  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
0.08  Max.  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
Banana  0.081)  Median  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
0.08  Max.  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
Mango  0.081)  Median  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
0.08  Max.  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
Root and tuber vegetables  0.016  TFA  concentration 
found  in  rotational 
crop  metabolism 
study  with 
trifloxystrobin  in 
white  radish.  See 
Table 4-4.  
0.016  TFA  concentration 
found  in  rotational 
crop  metabolism 
study  with 
trifloxystrobin  in 
white  radish.  See 
Table 4-4.  
Bulb vegetables  0.016  0.016 Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Commodity  Chronic exposure assessment  Acute exposure assessment 
Input value 
(mg/kg) 
Comment  Input value 
(mg/kg) 
Comment 
Fruiting vegetables  0.068  TFA  concentration 
found  in  rotational 
crop  metabolism 
study  with fluazinam 
in  lettuce.  See  Table 
4-4.  
0.068  TFA  concentration 
found  in  rotational 
crop  metabolism 
study  with 
fluazinam  in 
lettuce.  See  Table 
4-4.  
Brassica vegetables  0.068  0.068 
Leafy vegetables  0.068  0.068 
Legume vegetable  0.165  Median  residue 
(saflufenacil)  *  CF 
(16.5)  (See  table  4-3 
of EFSA, 2012a) 
0.165  Max.  residue 
(saflufenacil)  *  CF 
(16.5) (See table 4-
3 of EFSA, 2012a) 
Stem vegetables  0.068  TFA  concentration 
found  in  rotational 
crop  metabolism 
study  with fluazinam 
in  lettuce.  See  Table 
4-4.  
0.068  TFA  concentration 
found  in  rotational 
crop  metabolism 
study  with 
fluazinam  in 
lettuce.  See  Table 
4-4.  
Pulses  0.165  Median  residue 
(saflufenacil)  *  CF 
(16.5)  (See  table  4-3 
of EFSA, 2012a).  
0.165  Median  residue 
(saflufenacil)  *  CF 
(16.5) (See table 4-
3 of EFSA, 2012a) 
Soya beans  0.165  0.165 
Other oilseeds  0.068  Median  residue 
(saflufenacil)  *  CF 
(16.5)  (See  table  4-3 
of EFSA, 2012a) 
0.068  Median  residue 
(saflufenacil)  *  CF 
(16.5) (See table 4-
3 of EFSA, 2012a) 
Cereals  0.08  Median  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
0.08  Median  residue 
(saflufenacil)  *  CF 
(8) (See table 4-3 of 
EFSA, 2012a) 
Coffee  0.08  0.08 
Other crops  0.01  Potential contribution 
of  background  TFA 
levels  at  the  LOQ; 
see Table 4-5. 
0.01  Potential 
contribution  of 
background  TFA 
levels  at  the  LOQ; 
see Table 4-5. 
Food of animal origin  0  No  contribution  to 
TFA  exposure  via 
food of animal origin 
expected.  
0  No  contribution  to 
TFA  exposure  via 
food  of  animal 
origin expected.  
(1): A sensitivity analysis is performed to assess the impact of the conservative input values (LOQ for saflufenacil (0.01 
mg/kg) 
(*): CF (8) = 0.08 mg/kg) compared with the less conservative approach proposed by the applicant (LOD for saflufenacil 
(0.002 mg/kg) * CF (8) = 0.016 mg/kg); further explanations see section 4.2.1.1. 
 
4.4.  Results of consumer dietary risk assessment for TFA  
The estimated TFA exposure was compared with the proposed toxicological reference value derived 
for TFA (see Table 1-1). The results of the intake calculation are presented in Appendix E to this 
reasoned opinion. The overall uncertainties of the calculation should be borne in mind when deriving 
conclusions from the exposure assessment.  Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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No long-term consumer intake concerns were identified for any of the European diets incorporated in 
the  EFSA  PRIMo.  The  total  calculated  intake  accounted  for  up  to  5 %  of  the  ADI.  The  major 
contributors in this calculation were apples (up to 1.9% of the ADI), wheat (up to 1.4% of the ADI) 
and  oranges  and  wine  grapes  (both  0.6%  of  the  ADI,  respectively).  The  sensitivity  analysis 
demonstrated that the conservative approach used for fruit crops has an impact on the outcome of the 
exposure assessment; thus, replacing the input values for these fruit crops with a less conservative 
input value as proposed by the applicant the overall long-term exposure accounted for maximum of 
3.9% of the ADI.  
No acute consumer risk was identified in relation to the estimated TFA concentrations in food. The 
calculated  maximum  exposure  in  percentage  of  the  ARfD  was  24.6 %  for  potatoes,  followed  by 
oranges (21.2% of the ARfD) and apples (15.7% of the ARfD).  
To  verify  the  results  of  the  dietary  exposure  assessment  it  would  be  desirable  to  generate  more 
experimental data on the actual residue concentrations for TFA in food. For this purpose the setting up 
of  a  monitoring  programme  could  be  considered.  An  additional  argument  for  a  more  specific 
monitoring is the fact that in future a further increase of TFA concentrations in environmental is 
expected as a result of the increased use of HCFC/HFCs  which may lead to increased consumer 
exposure.    
On  the  basis  of  the  information  available  to  EFSA  and  the  current  scientific  knowledge,  EFSA 
concludes that for the intended use of saflufenacil on the crops for which MRLs were requested in the 
framework of the MRL application (EFSA-Q-2011-00208), including the CXLs established by Codex 
Alimentarius  Commission  in  2012,  the  TFA  exposure  via  the  diet  will  not  result  in  a  consumer 
exposure exceeding the toxicological reference values derived for this metabolite  and therefore is 
unlikely to pose a public health concern. In this assessment also the use of other pesticides which are 
known to lead to the formation of TFA has been included as far as the data were available to EFSA 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
The toxicological profile of the active substance saflufenacil was assessed in the previously issued 
reasoned opinion of EFSA. The data were sufficient to derive an ADI of 0.046 mg/kg bw per day and 
an ARfD of 0.05 mg/kg bw. For the metabolite TFA, on the basis of toxicological studies that were 
made available for this assessment, EFSA concluded that it is possible to derive a tentative ADI of 
0.05 mg/kg bw per day and a tentative ARfD at the same level (0.05 mg/kg bw).  
EFSA was asked to address concerns to what extent TFA may exert local irritative effects  in the 
gastro-intestinal tract, considering that the free acid (trifluoroacetic acid) is classified and labelled as 
corrosive. Considering the pH levels in food and the low concentrations TFA will not occur as free 
acid but in form of its salt. Thus, the irritative effects observed with the free acid are of low relevance 
in the framework of this assessment.   
The  European  Commission  asked  EFSA  to  assess  the  toxicokinetics  of  TFA  following  oral 
administration, since according to the Danish position paper this information is indispensable if the 
TTC approach should be applied. EFSA concludes that lacking these studies, no final conclusions can 
be  derived.  However,  the  Danish  concern  is  considered  to  be  sufficiently  addressed  as  it  is  not 
necessary to base the risk assessment for TFA on the TTC approach but on specific toxicological 
reference values derived for TFA.  
EFSA was also requested to update the consumer risk assessment of the previously issued opinion on 
saflufenacil, taking into account the MRLs established by Codex Alimentarius Commission (CXLs) in 
July 2012 and additional information provided in the position papers of the United Kingdom and 
Denmark. Considering the argumentation presented in the position paper of the United Kingdom, 
EFSA revised its previous opinion and derived MRL proposals for coffee and potatoes (0.03 mg/kg, 
respectively). However, EFSA noted that considering the short PHI specified in the GAP for coffee Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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the  EU  data  requirements  regarding  metabolism  studies  are  not  fully  addressed.  To  clarify  the 
situation, the applicant should provide further explanations if the short PHI is relevant in practice. 
Also for potatoes, further metabolism studies would be desirable to confirm the assumption that after 
desiccation use of saflufenacil the metabolic profile in roots is comparable to the one found in soya 
beans.  
EFSA  updated  the  chronic  and  acute  exposure  assessment  for  saflufenacil,  including  the  CXLs 
adopted  in  2012  and  the  MRL  proposals  for  coffee  and  potatoes.  No  consumer  concerns  were 
identified: the long-term (chronic) exposure accounted for a maximum of 3.2 % of the ADI (UK 
toddler)  while  the  short-term  (acute) exposure  did  not  exceed  10 %  of the  ARfD  for  any  of  the 
commodities for which MRL proposals were derived (maximum for bovine liver: 9.4% of the ARfD). 
On  the  basis  of  this  updated  dietary  exposure  assessment  for  saflufenacil  (including  metabolite 
M800H11 and M800H35), EFSA concludes that the MRLs derived by EFSA, including the CXLs 
adopted in 2012 in the EU legislation do not pose a consumer health concern.  
For TFA a comprehensive dietary consumer exposure assessment was performed as requested by the 
European Commission taking into account all sources. Thus, for the calculation of the long-term and 
short-term exposure the following sources of exposure were considered:  
TFA residues in primary crops resulting from the use of saflufenacil; 
TFA residues in rotational crops grown on fields previously treated with saflufenacil;   
TFA residues resulting from other pesticides that are metabolised to TFA and where measurable TFA 
concentrations are expected in primary or rotational crops;  
TFA residues in food resulting from environmental contaminations (see Section 4.2.3). 
To derive the input values for the exposure assessments, a conservative approach was applied using 
highest TFA concentrations described in relevant studies identified in dossiers of saflufenacil or other 
pesticides or in the public domain. Since the input values derived for the comprehensive exposure 
assessment are subject to a high level of uncertainty, the results of the exposure assessment are less 
accurate compared with standard exposure assessments. For the interpretation of the results these 
uncertainties should be born in mind, meaning that they give an indicative estimation of the order of 
magnitude of the exposure. The total calculated intake accounted for up to 5 % of the ADI. The major 
contributors in this calculation were apples (up to 1.9% of the ADI), wheat (up to 1.4% of the ADI) 
and oranges and wine grapes (both 0.6% of the ADI, respectively).  
No acute consumer risk was identified in relation to the estimated TFA concentrations in food. The 
calculated  maximum  exposure  in  percentage  of  the  ARfD  was  24.6 %  for  potatoes,  followed  by 
oranges (21.2% of the ARfD) and apples (15.7% of the ARfD).  
To  verify  the  results  of  the  dietary  exposure  assessment  it  would  be  desirable  to  generate  more 
experimental data in the framework of a monitoring programme on TFA in food.  
On  the  basis  of  the  information  available  to  EFSA  and  the  current  scientific  knowledge,  EFSA 
concludes that for the intended use of saflufenacil on the crops for which MRLs were requested in the 
framework of the MRL application (EFSA-Q-2011-00208), including the CXLs established by Codex 
Alimentarius Commission, the TFA exposure via the diet  will not result in a consumer exposure 
exceeding the toxicological reference values derived for this metabolite and therefore is unlikely to 
pose a public health concern. Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Recommendations 
Code 
number
a 
Commodity  Existing EU 
MRL 
(mg/kg) 
Proposed EU 
MRL (mg/kg) 
Justification for the proposal 
The proposed import tolerances and CXLs reported below are sufficiently supported by data and no consumer 
intake  concerns  were  identified  with  regard  to  the  residue  definition  for  risk  assessment.  Regarding  the 
metabolite TFA a separate risk assessment was performed which did not raise intake concerns.  
Enforcement residue definition for commodities of plant origin: the sum of saflufenacil, M800H11 and 
M800H35, expressed as saflufenacil 
0110000  Citrus fruit  0.01* 
(default 
MRL) 
0.03*  Import  tolerance  for  grapefruit, 
oranges,  lemons  assessed  in 
EFSA Journal 2012;10(2):2596, 
CXL
b for whole group of citrus  
0120000  Tree nuts  0.03*  Import  tolerance  for  almonds 
and  pecans  assessed  in  EFSA 
Journal 2012;10(2):2596, CXL
b 
for whole group of tree nuts 
0130000  Pome fruit  0.03*  Import tolerance for  apples and 
pears assessed in EFSA Journal 
2012;10(2):2596,  CXL
b  for 
whole group of pome fruit 
0140000  Stone fruit  0.03*  Import  tolerance  for  cherries, 
peaches and plums assessed in 
EFSA Journal 2012;10(2):2596, 
CXL
b for whole group of stone 
fruit 
0151000  Table and wine grapes   0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0163020  Banana   0.03*
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0163030  Mangoes  0.03*
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0211000  Potatoes  0.03*  Import tolerance re-evaluated in 
this reasoned opinion 
0234000  Sweet corn   0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0260000  Legume vegetables (fresh)  0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0300010  Dry beans  0.5
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0300030  Dr peas  0.1
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0401070  Soya bean  0.1
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0401050  Sunflower seed   1.0
  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0401060  Rape seed  0.6  CXL established in 2012  
0401090  Cotton seed  0.3  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Code 
number
a 
Commodity  Existing EU 
MRL 
(mg/kg) 
Proposed EU 
MRL (mg/kg) 
Justification for the proposal 
0500000 
(except 
0500020) 
Cereals  (except 
buckwheat) 
0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0900020  Sugarcane  0.03*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
0620000  Coffee beans  0.03*  Import tolerance re-evaluated in 
this  reasoned  opinion;  further 
explanations should be provided 
concerning  the  PHI  relevant  in 
practice  to  confirm  that  the 
metabolism  studies  are 
representative for the use.  
Enforcement residue definition for commodities of animal origin: saflufenacil 
1011010 
1011020 
Swine meat 
Swine fat 
0.01* 
(default 
MRL) 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1011030 
1011040 
Swine liver 
Swine kidney 
0.3  For  liver  the  import  tolerance 
was  derived  in  EFSA  Journal 
2012;10(2):2596, for kidney the 
CXL should be taken over.   
1012010 
1013010 
1014010 
Bovine meat 
Sheep meat 
Goat meat 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1012020 
1013020 
1014010 
Bovine fat 
Sheep fat 
Goat fat 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1012030 
1013030 
1014030 
Bovine liver 
Sheep liver 
Goat liver 
0.6  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1012040 
1013040 
1014040 
Bovine kidney 
Sheep kidney 
Goat kidney 
0.3  CXL derived in 2012.  
1016000  Poultry  meat,  fat,  liver, 
kidney, edible offal 
0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1020000  Milk  0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
1030000  Eggs  0.01*  Import  tolerance  assessed  in 
EFSA Journal 2012;10(2):2596 
(*):  Indicates that the MRL is set at the limit of analytical quantification. 
(a):  According to Annex I of Regulation (EC) No 396/2005. 
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APPENDICES  
Appendix A.   Good Agricultural Practices (GAPs) for potatoes and coffee 
Crop and / 
or 
situation 
(a) 
Member 
State or 
Country 
F  
G or 
I 
(b) 
Pest or 
group of pests 
controlled 
I 
Formulation  Application  Application rate per treatment  PHI 
(days) 
(k) 
Remarks: 
Maximum 
applied 
amount 
(kg a.s./ha) 
(l) 
Type 
(d – f) 
Conc. Of 
a.s. 
(i) 
method, 
kind 
(f – h) 
growth stage 
(j) 
number 
(range) 
kg 
a.s./
hl 
water l/ha  kg a.s./ha 
Potatoes  BR  F  Broadleaf 
weeds  WG  70  SP  Desiccation  1    200 – 300  0.050 – 0.100  7  Max. 0.10 
Coffee 
BR  F  Broadleaf 
weeds  WG  70  SP  Postemergence  3    100 – 150  0.025 – 0.050  7  Max. 0.150 
Costa Rica, 
Ecuador  F  Broadleaf 
weeds  WG  70  SP  postemergence  4      0.100  0 or 1  Max. 0.400 
Remarks:  (a) 
 
(b) 
I 
(d) 
(e) 
 
(f) 
(g) 
For crops, EU or other classifications, e.g. Codex, should be used; where 
relevant, the use situation should be described (e.g. fumigation of a structure)  
Outdoor or field use (F), glasshouse application (G) or indoor application (I) 
e.g. biting and suckling insects, soil born insects, foliar fungi, weeds 
e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR) 
GCPF Technical Monograph No 2, 4
th Ed., 1999 or other codes, e.g. 
OECD/CIPAC, should be used 
All abbreviations used must t be explained 
Method, e.g. high volume spraying, low volume spraying, spreading, 
37usting, drench 
(h) 
 
(i) 
(j) 
 
 
(k) 
 
(l) 
(m) 
Kind, e.g. overall, broadcast, aerial spraying, row, individual plant, between the plants – 
type of equipment used must be indicated 
g/kg or g/l 
Growth stage at last treatment (Growth stages of mono-and dicotyledonous plants. 
BBCH Monograph, 2
nd Ed., 2001), including where relevant, information on season at 
time of application 
The minimum and maximum number of application possible under practical conditions 
of use must be provided 
PHI – minimum pre-harvest interval 
Remarks may include: Extent of use/economic importance/restrictions (i.e. feeding, 
grazing) 
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Appendix B.  Pesticide Residue Intake Model (PRIMO) – SAFLUFENACIL 
updated risk assessment including CXLs adopted in 2012, potatoes and coffee  
Status of the active substance: Not included Code no.
LOQ (mg/kg bw): 0,03 proposed LOQ:
ADI (mg/kg bw/day): 0,046 ARfD (mg/kg bw): 0,05
Source of ADI: UK, EFSA Source of ARfD: UK, EFSA
Year of evaluation: 2011 Year of evaluation: 2011
1 3
No of diets exceeding ADI: ---
Highest calculated 
TMDI values in % 
of ADI  MS Diet
Highest contributor 
to MS diet 
(in % of ADI)
2nd contributor to 
MS diet 
(in % of ADI)
3rd contributor to 
MS diet 
(in % of ADI)
Commodity / 
group of commodities
pTMRLs at 
LOQ
(in % of ADI)
3,2 UK Toddler 1,5 0,4 0,3 Wheat 3,1
3,1 WHO Cluster diet B  0,6 0,4 0,3 Solanacea 2,6
3,0 NL child 0,6 0,4 0,4 Potatoes 2,9
2,8 DE child 0,8 0,3 0,3 Wheat 2,7
2,8 UK Infant  0,8 0,7 0,2 Potatoes 2,7
2,6 FR toddler 0,9 0,3 0,2 Other root and tuber vegetables 2,5
2,5 WHO cluster diet E 0,8 0,3 0,3 Potatoes 1,6
2,5 IE adult 0,2 0,2 0,1 Maize 2,2
1,9 DK child 0,4 0,3 0,3 Milk and cream,  1,8
1,8 WHO cluster diet D 0,4 0,3 0,2 Sunflower seed 1,5
1,8 WHO Cluster diet F  0,4 0,2 0,2 Potatoes 1,3
1,7 FR infant 0,6 0,3 0,2 Other root and tuber vegetables 1,7
1,6 ES child 0,3 0,3 0,1 Oranges 1,5
1,6 SE  general population 90th percentile 0,3 0,3 0,2 Wheat 1,6
1,6 WHO regional European diet  0,3 0,2 0,2 Rape seed 1,3
1,5 PT General population 0,3 0,3 0,2 Wine grapes 1,3
1,2 NL general 0,2 0,1 0,1 Wheat 1,1
1,2 FR all population 0,3 0,2 0,2 Sunflower seed 1,0
1,1 IT kids/toddler 0,4 0,1 0,1 Other cereal 1,1
1,0 ES adult 0,2 0,1 0,1 Oranges 1,0
1,0 UK vegetarian 0,2 0,1 0,1 Potatoes 1,0
0,9 UK Adult  0,3 0,1 0,1 Potatoes 0,9
0,8 DK adult 0,1 0,1 0,1 Potatoes 0,8
0,8 LT adult 0,2 0,1 0,1 Milk and cream,  0,8
0,8 IT adult 0,3 0,1 0,1 Leaf vegetables & fresh herbs 0,8
0,6 PL  general population 0,2 0,1 0,1 Solanacea 0,6
0,6 FI  adult 0,1 0,1 0,1 Wheat 0,6
Milk and cream, 
Wheat
Potatoes
Wheat
Potatoes
Wheat
Wheat
Sugar beet (root)
Sugar beet (root)
Potatoes
Potatoes
Potatoes
Wine grapes
Rape seed
Milk and cream, 
Wheat
Potatoes
Rape seed
Sheep: Liver
Wheat
Wheat
Milk and cream, 
Apples
Milk and cream, 
Milk and cream, 
Conclusion:
The estimated Theoretical Maximum Daily Intakes (TMDI), based on pTMRLs were below the ADI. 
A long-term intake of residues of  Saflufenacil is unlikely to present a public health concern.
Saflufenacil
Toxicological end points
                     TMDI (range) in % of ADI
                        minimum - maximum
Chronic risk assessment - refined calculations
Commodity / 
group of commodities
Commodity / 
group of commodities
Sugar beet (root)
Wheat
Milk and cream, 
Sunflower seed
Apples
Milk and cream, 
Sugar beet (root)
Potatoes
Wheat
Tropical root and tuber vegetables
Rye
Potatoes
Wheat
Potatoes
Milk and cream, 
Wheat
Wheat
Milk and cream, 
Wheat
Solanacea
Milk and cream, 
Wheat
Milk and cream,  Potatoes
Apples
Wheat
Milk and cream, 
Apples
Solanacea
Prepare workbook for refined 
calculations
Undo refined calculations
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The acute risk assessment is based on the ARfD.
--- --- --- ---
IESTI 1 *) **) IESTI 2 *) **) IESTI 1 *) **) IESTI 2 *) **)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
9.4 Bovine: Liver 0.58 / - 9.4 Bovine: Liver 0.58 / - 3.1 Bovine: Liver 0.58 / - 3.1 Bovine: Liver 0.58 / -
9.2 Potatoes 0.03 / - 6.6 Potatoes 0.03 / - 1.9 Table grapes 0.03 / - 1.9 Table grapes 0.03 / -
8.0 Oranges 0.03 / - 5.8 Oranges 0.03 / - 1.8 Potatoes 0.03 / - 1.4 Wine grapes 0.03 / -
5.9 Apples 0.03 / - 5.4 Grapefruit  0.03 / - 1.5 Oranges 0.03 / - 1.4 Potatoes 0.03 / -
5.5 Pears 0.03 / - 4.3 Apples 0.03 / - 1.4 Wine grapes 0.03 / - 1.2 Oranges 0.03 / -
5.4 Grapefruit  0.03 / - 3.9 Pears 0.03 / - 1.3 Apples 0.03 / - 1.2 Mangoes 0.02 / -
5.0 Bananas 0.03 / - 3.9 Table grapes 0.03 / - 1.3 Sweet corn 0.03 / - 1.1 Apples 0.03 / -
4.4 Sweet corn 0.03 / - 3.6 Bananas 0.03 / - 1.3 Pears 0.03 / - 1.0 Pears 0.03 / -
3.9 Table grapes 0.03 / - 3.1 Sweet corn 0.03 / - 1.2 Grapefruit  0.03 / - 0.9 Sweet corn 0.03 / -
3.6 Peaches 0.03 / - 2.6 Peaches 0.03 / - 1.2 Mangoes 0.02 / - 0.9 Grapefruit  0.03 / -
3.3 Mandarins  0.03 / - 2.5 Mandarins  0.03 / - 1.0 Peaches 0.03 / - 0.8 Peaches 0.03 / -
3.1 Mangoes 0.02 / - 2.5 Milk and milk 
products: Cattle
0.01 / - 0.8 Bananas 0.03 / - 0.8 Sheep: Liver 0.58 / -
2.5 Milk and milk 
products: Cattle
0.01 / - 2.2 Mangoes 0.02 / - 0.8 Mandarins  0.03 / - 0.6 Bananas 0.03 / -
2.1 Lemons 0.03 / - 1.6 Plums 0.03 / - 0.8 Sheep: Liver 0.58 / - 0.6 Mandarins  0.03 / -
2.0 Plums 0.03 / - 1.5 Lemons 0.03 / - 0.6 Plums 0.03 / - 0.5 Wheat 0.03 / -
1.9 Apricots 0.03 / - 1.5 Apricots 0.03 / - 0.5 Quinces 0.03 / - 0.5 Plums 0.03 / -
1.3 Rape seed 0.6 / - 1.3 Rape seed 0.6 / - 0.5 Wheat 0.03 / - 0.5 Rice 0.03 / -
1.2 Limes 0.03 / - 1.1 Beans 0.03 / - 0.5 Apricots 0.03 / - 0.4 Barley  0.03 / -
1.1 Beans 0.03 / - 0.9 Wheat 0.03 / - 0.5 Rice 0.03 / - 0.4 Apricots 0.03 / -
0.9 Quinces 0.03 / - 0.9 Limes 0.03 / - 0.4 Barley  0.03 / - 0.4 Quinces 0.03 / -
0.9 Wheat 0.03 / - 0.8 Rice 0.03 / - 0.4 Lemons 0.03 / - 0.4 Beans 0.03 / -
0.8 Rice 0.03 / - 0.7 Cherries 0.03 / - 0.4 Limes 0.03 / - 0.3 Milk and milk products: Cattle 0.01 / -
0.7 Cherries 0.03 / - 0.7 Quinces 0.03 / - 0.4 Beans 0.03 / - 0.3 Swine: Liver 0.25 / -
No of critical MRLs (IESTI 1) --- No of critical MRLs (IESTI 2) ---
--- ---
***) ***)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
For processed commodities, no exceedance of the ARfD/ADI was identified.
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*) The results of the IESTI calculations are reported for at least 5 commodities. If the ARfD is exceeded for more than 5 commodities, all IESTI values > 90% of ARfD are reported. 
**) pTMRL: provisional temporary MRL
***) pTMRL: provisional temporary MRL for unprocessed commodity
No exceedance of the ARfD/ADI was identified for any unprocessed commodity. 
 
Acute risk assessment /children - refined calculations Acute risk assessment / adults / general population - refined calculations
Conclusion:
For Saflufenacil IESTI 1 and IESTI 2 were calculated for food commodities for which pTMRLs were submitted and for which consumption data are available.
In the IESTI 1 calculation, the variability factors were 10, 7 or 5 (according to JMPR manual 2002), for lettuce a variability factor of 5 was used. 
In the IESTI 2 calculations, the variability factors of 10 and 7 were replaced by 5. For lettuce the calculation was performed with a variabilty factor of 3.  
No of commodities for which ARfD/ADI is 
exceeded (IESTI 2):
For each commodity the calculation is based on the highest reported MS consumption per kg bw and the corresponding unit weight from the MS with the critical consumption. If no data on the unit weight was available from that MS an average 
European unit weight was used for the IESTI calculation. 
No of commodities for which 
ARfD/ADI is exceeded:
No of commodities for which ARfD/ADI 
is exceeded:
Threshold MRL is the  calculated residue level which would leads to an exposure equivalent to 100 % of the ARfD.  
No of commodities for which ARfD/ADI 
is exceeded (IESTI 1):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 2):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 1):
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Appendix C.  Screening of approved and pending active substances: evidence of the formation of TFA in metabolism studies 
Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Approved active substances containing the R-CF3 - group 
Acrinathrin  AC 
 
EFSA 
conclusion 
no   
Beflubutamid  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005, 
DAR  
no   
Benfluralin  HB 
 
EFSA 
conclusion,  
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005, 
BASF, 2011 
yes,  
rotational crop 
metabolism 
TFA  was  the  major  metabolite  in  rotational  crop  studies  in  all  tested 
commodities (28 – 77% of TRR; 0.006 to 0.137 ppm
9). (BASF, 2011).  
Since TFA was not described in the DAR or in the EFSA conclusion or in 
Art. 12 review, no detailed results are available for the different crops/crop 
parts  tested.  The  derivation  of  residue  concentrations  to  be  used  for  a 
quantitative exposure assessment is not possible.  
                                                       
9 Lacking further details it is not clear if the concentrations refer to benfluralin equivalents or concentrations expressed as TFA.  Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Bifenthrin  IN, AC 
 
EFSA 
conclusion 
no   
Cyflufenamid  FU 
 
EFSA 
conclusion 
no   
Cyflumetofen  AC 
 
EFSA 
conclusion 
no  Default MRL 0.01 mg/kg, no use of food or feed (only ornamentals) Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Cyhalothrin, 
Lambda- 
IN 
 
DAR  no   
Diflufenican  HB 
 
EFSA 
conclusion 
no   
Fipronil  IN 
 
EFSA 
conclusion, 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no   Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Flazasulfuron  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no   
Flonicamid  IN 
 
EFSA 
conclusion 
no   
Fluazifop-P  HB 
 
EFSA 
conclusion 
no   
Fluazinam  FU 
 
EFSA 
conclusion, 
DAR 
yes 
primary  crop 
metabolism 
study 
 
 
 
 
 
rotational crop 
metabolism 
study 
TFA was found in primary and rotational crop studies, but not in rat 
metabolism. It was classified as a toxicologically relevant compound.  
Primary crop studies: 
potatoes (tuber): <0.001 mg eq./kg, (0.9% TRR), corresponding to <0.00025 
mg TFA/kg; 
peanut (foliage): 0.87 mg eq./kg, (3.4%TRR), corresponding to 0.22 mg 
TFA/kg; 
apples: 0.023 mg eq/kg, (1.23% TRR), corresponding to 0.0058 mg TFA/kg.  
 
Rotational  crop  studies  (dose  rate  tested:  total  annual  rate  of  fluazinam 
applied on bare soil)  
Lettuce: maximum 0.27 mg eq./kg, corresponding to 0.068 mg TFA/ha;  
Barley  grain:  maximum:  0.18 mg  eq/kg  (amount  was increasing  with  the 
plant interval), corresponding to 0.045 mg TFA/kg;  
Carrot roots: maximum 0.057 mg eq/kg, corresponding to 0.014 mg TFA/kg.  Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Flufenacet  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no   
Fluometuron  HB 
 
EFSA 
conclusion, 
DAR 
yes,  primary 
crop 
metabolism 
study 
TFAA was observed in primary crop metabolism study in cotton, the only 
crop  where  the  active  substance  is  intended  to  be  used.  Studies  were 
conducted with 2.5N the dose intended under the cGAP.  
cotton (immature stalks): 18% of the TRR (0.23 ppm); 
cotton (mature stalks): 31% (0.084 ppm) 
cotton (seed): 21.5% TRR (0.0155 ppm
10).  
TFA was proposed for a risk assessment residue definition for pulses and 
oilseeds. EFSA concluded that for other crops TFA might be included in the 
RD depending on the assessment of the toxicological properties of TFA.  
A data gap was identified in the toxicology section to address the 
toxicological properties of the plant metabolite trifluoroacetic acid (TFA). 
Fluopicolide  FU 
 
EFSA 
conclusion 
no   
Fluopyram  FU 
 
EFSA 
conclusion 
no   
                                                       
10 Lacking further details it is not clear if the concentrations refer to benfluralin equivalents or concentrations expressed as TFA.  Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Flupyrsulfuron-
methyl 
HB 
 
EFSA  RO 
under  Art.  12 
of  Regulation 
396/2005 
no   
Flurochloridone  HB 
 
EFSA 
conclusion 
no   
Flurtamone  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
yes,  
rotational crop 
studies 
Rotational  crop  studies:  The  soil  metabolite  trifluoroacetic  acid  was the 
main component of the TRR.  
wheat (grain): 79.9 % of the TRR (0.061 mg eq./kg; corresponding to 0.021 
mg TFA/kg)  
wheat (straw): 33.8 % of the TRR (0.069 mg eq./kg; corresponding 0.024 mg 
TFA/kg).  
The studies were performed with a dose rate slightly higher than the intended 
use rate (1.3N) and represent a worst case in terms of expected residues due 
to  the  bare  soil  application.  Under  practical  conditions,  residues  of  the 
metabolite are not expected to exceed 0.01 mg/kg in rotational crops. 
Flutolanil  FU 
 
EFSA 
conclusion  
no   Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Fluvalinate, tau-  IN 
 
EFSA 
conclusion 
no   
Haloxyfop-R  HB 
 
EFSA 
conclusion 
yes  TFA was observed in lysimeter studies.  
The annual average concentration measured was 0.085µg/L in spring studies 
and 0.079 μg/L in the autumn study. The peer review experts agreed that, as 
the trigger value of 0.1 μg/L was not reached, no further assessment (i.e. 
groundwater modelling) was necessary for trifluoroacetic acid. 
Indoxacarb  IN 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no   
Isoxaflutole  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no   
Lufenuron  IN 
 
EFSA 
conclusion 
no   Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Oxyfluorfen  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
yes,  primary 
corp 
metabolism  
TFA was observed in primary crop metabolism studies in alfalfa, but not in 
root  and  tuber  (onion)  and  fruit  crops  (tomato,  peach,  apple).  The  active 
substance was applied post-emergence on onion and alfalfa, directly onto the 
soil  in  dormant  apple  and  peach  trees,  and  pre-plantation  of  tomato. 
Application rates ranged from 2.2 to 11.2 kg a.s/ha (2-8 times grater than the 
maximum use rates).  
TFA was observed as a major metabolite in alfalfa, its amounts increasing 
with time from 17% to 53% TRR (0.02 to 0.11 mg eq/kg). 
Penoxsulam  HB 
 
EFSA 
conclusion 
 
no   
Penthiopyrad  FU 
 
EFSA 
conclusion 
no   
Picolinafen  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no    Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Picoxystrobin  FU 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no   
Prosulfuron  HB 
 
EFSA  RO 
under  Art.  12 
of  Reg. 
396/2005  
no   
Pyroxsulam  HB 
 
EFSA 
conclusion 
no   Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Tefluthrin  IN 
 
EFSA 
conclusion 
no   
Tembotrione  HB 
 
EFSA 
conclusion 
no   
Trifloxystrobin  FU 
 
JMPR 
evaluation 
2004 
yes,  primary 
crop 
metabolism 
and  rotational 
crop 
metabolism 
Primary crop metabolism studies:  
Immature peanut vines (treated with 4*560 g a.s./ha) contained 0.025 mg 
eq/kg (corresponding to 0.007 mg TFA/kg); 
peanuts (mature hay): 0.217 mg eq/kg, corresponding to 0.06 mg TFA/kg.  
 
Rotational crop metabolism studies:  
Studies conducted by applying [14C-phenyl]trifloxystrobin and [14C-phenyl] 
trifloxystrobin to bare soil at a rate of 500 g a.s./h. TFA was the major 
metabolite in rotational crop metabolism studies especially in spring wheat 
and radish, accounting for up to 65.7% of the TRR (0.016 mg/kg).   
As trifluoroacetic acid was not observed as a plant metabolite in most target 
crops after foliar application (except very low amounts in peanuts), JMPR 
concluded that it is likely that its precursor is formed in the soil or 
rhizosphere of the plants. Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Triflumizole  FU 
 
EFSA 
conclusion 
no   
Triflusulfuron  HB 
 
EFSA 
conclusion 
no   
Tritosulfuron  HB 
 
DAR  no  In  primary  crop  metabolism  study  in  maize  a  metabolite  was  identified 
(635M01) which was formed by opening the triazine ring and elimination of 
trifluoroacetic acid. However, the complementary metabolite TFA was not 
directly identified.  
Pending active substances containing the R-CF3 - group 
Flumetralin  PG 
 
-  -  No DAR available yet; default MRL of 0.01 mg/kg Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Active substance  Pesticide 
category 
Chemical structure  Source of 
information 
TFA 
identified in 
metabolism 
studies 
Comment 
Flutianil  FU 
 
DAR  no  No MRLs established yet.  
 
Metaflumizone  IN 
 
DAR  no   
Pyridalyl  IN 
 
DAR  no   
Sulfoxaflor  IN 
 
DAR  no  No MRLs established yet 
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List of non-approved active substances containing the TFA common moiety  
Pesticide  Mode of Action 
Acetoprole  Acaricide, Insecticide 
Acifluorfen  Herbicide 
Acifluorfen-methyl  herbicides 
Amidoflumet  Acaricide 
Bencarbazone  Herbicide 
Benzfendizone  Herbicide 
Benzofluor  Herbicide, Growth 
regulator 
Bicyclopyrone  Herbicide 
Bistrifluron    
Bromethalin  Rodenticide 
Butafenacil  Herbicide 
Chlorfenapyr  Acaricide, Insecticide 
Chlorfluazuron  Insecticide 
Chlorflurazole  herbicides 
Cyhalothrin, 
gamma- 
Insecticide 
Difenopenten  herbicides 
Dinitramine  Herbicide 
Dithiopyr  Herbicide 
Ethalfluralin  Herbicide 
Ethiprole  Insecticide 
Fenazaflor  Acaricide 
Fentrifanil  acaricides 
Flocoumafen  Rodenticide 
flometoquin  Insecticides 
Fluacrypyrim  Acaricide 
Fluazifop  Herbicide 
Fluazifop-methyl  Herbicides 
Fluazifop-P-Butyl  Herbicide 
Fluazolate  Herbicide 
Fluazuron    
Flubendiamide  Insecticide 
Flubenzimine  Acaricide, Growth 
regulator 
Flucarbazone  Herbicide 
Fluchloralin  Herbicide 
Flufenapyr-ethyl  herbicides 
Flufenican  herbicides 
Flufenoxuron  Acaricide, Insecticide 
Flufenoxystrobin  acaricides; fungicides 
Flufenprox  Insecticide 
Flufiprole  Insecticide 
Flumezin  herbicides 
Fluoridamid  growth inhibitors 
Fluorodifen  Herbicide 
Fluoroglycofen  Herbicide 
Fluoroglycofen-
Ethyl 
Herbicide 
Fluoroglycofen-
ethyl 
herbicides 
Fluotrimazole  Fungicide 
Flupoxam  Herbicide 
Flupyrsulfuron  Herbicide 
Pesticide  Mode of Action 
Flurazole  Herbicide safener 
Fluridone  Herbicide 
Flurprimidol  Growth regulator 
Flusulfamide  Fungicide 
Fluvalinate  Acaricide, Insecticide 
Fluxofenim  Herbicide safener 
Fomesafen  Herbicide 
Fucaomi  herbicides 
Funaihecaoling  herbicides 
Furconazole  Fungicide 
Heptafluthrin  insecticides 
Hydramethylnon  Insecticide 
Lactofen  Herbicide 
Mefluidide  Growth regulator, 
Herbicide 
Methalpropalin  herbicides 
Nipyraclofen  herbicides 
Norflurazon  Herbicide 
Novaluron  Insecticide 
Noviflumuron  Insecticide 
Oxathiapiprolin  fungicides 
Penfluron  Insecticide 
Perfluidone  Herbicide 
Prodiamide  herbicides 
Profluralin  Herbicide 
Pyflubumide  Acaricide 
Pyrafluprole  insecticides 
Pyrasulfotole  Herbicide 
Pyrifluquinazon  Insecticide 
Pyrifluquinazon  Insecticides 
Pyriminostrobin  acaricides 
Pyriprole  herbicides 
Pyroxasulfone  Herbicide 
Thiazafluron  Herbicide 
Thiazopyr  Herbicide 
Thifluzamide  Fungicide 
Tiafenacil  herbicides 
Tolprocarb  Fungicide 
Triafamone  herbicides 
Trifloxysulfuron  Herbicide 
Trifluralin  Herbicide 
Triflusulfuron-
Methyl 
Herbicide 
Trifop  herbicides 
Trifop-methyl  herbicides 
Trifopsime  Herbicide 
Vaniliprole  acaricides/insecticides 
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Appendix D.  Screeining of approved and pending active substances regarding the formation of 
TFA in metabolism studies 
The following searches were executed by EFSA (SAS Unit). 
1.  Search in Web of Knowledge (WoK), 9/OCT/2013: 
Topic=(Trifluoroacet* OR "Trifluoro acet*" OR TFA OR TFAA OR trifluoressig* OR trifluoracet*) 
AND Topic=(food* OR vegetable* OR fruit* OR cereal* OR rice OR pulse* OR mushroom* OR 
meat OR liver OR fat OR kidney* OR milk OR egg* OR honey OR fish OR seafood* OR game OR 
poultry OR algae OR feed OR chicken OR turkey OR beer OR wine OR bread OR "dietary expo*") 
NOT Topic=("trans fat*")  
Timespan=All years.  
Search language=English   
 
 Results: 2632 hits, containing: 
  1.996 records from Web of Science 
  121 records from MEDLINE 
  322 records from CABI 
  1 record form Current Contents Connect 
  192 records from FSTA – the food science resource 
Saved in ENDNOTE-file: TFA-WoK.enl 
 
2.  Search in PubMed , 9/OCT/2013 
((((food* OR vegetable* OR fruit* OR cereal* OR rice OR pulse* OR mushroom* OR meat OR liver 
OR fat OR kidney* OR milk OR egg* OR honey OR fish OR seafood* OR game OR poultry OR 
algae  OR  feed  OR  chicken  OR  turkey  OR  beer  OR  wine  OR  bread  OR  "dietary 
exposure"[Title/Abstract]))) AND ((Trifluoroacetate OR Trifluoroacetic* OR "Trifluoro acetic" OR 
"Trifluoro acetate" OR TFA OR TFAA OR trifluoressigsaure OR trifluoracetat OR Trifluoro-acetate 
OR trifluoro-acetic[Title/Abstract]))) NOT ("Trans fatty" OR "trans fat"[Title/Abstract]) 
Pubmed translated the search in terms given in Annex A. 
•  Wildcard search for 'egg*' used only the first 600 variations. Lengthen the root word to search 
for all endings. 
•  The following term was not found in PubMed: trifluoressigsaure trifluoracetat  
Results: 917 hits 
Saved in ENDNOTE-file: TFA_PubMed.enl Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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Merging search results form PubMed and WoK: 3086 (463 duplicates) 
Saved in ENDNOTE-file: TFA_PubMed_plus_WoK.enl 
Removing duplicates in Distiller: 2757 
 
3.  Supplemental search for “residue” in Web of Knowledge 25/10/2013: 
Topic=(Trifluoroacetate OR "Trifluoro acetate*" OR TFA OR TFAA OR trifluoroacetic OR "trifluoro 
acetic") AND Topic=(residue*) NOT Topic=("fat acids" OR "fatty acids")  
Results:  985 hits 
Saved in ENDNOTE-file: TFA_residues_WoK.enl 
4.  Supplemental search for “residue” in Pubmed 25/10/2013: 
(residue*[Title/Abstract])  AND  ((Trifluoroacetate  OR  Trifluoroacetic*  OR  "Trifluoro  acetic"  OR 
"Trifluoro  acetate"  OR  TFA  OR  TFAA[Title/Abstract])))  NOT  ("fatty  acids"  OR  "fat 
acids"[Title/Abstract]) 
Pubmed translated the search in terms given in Annex B. 
Results: 508 hits 
Saved in ENDNOTE-file: TFA_residues_PubMed.enl 
Merged:1235 (258 duplicate) 
Merged with TFA_pubmed_plus_wok: 861 (374 duplicates) 
Saved in ENDNOTE-file: Merged_dietary_residues.enl 
Removing 170 duplicates in Distiller: 691 
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Appendix E.  Pesticide Residue Intake Model (PRIMO) – Results for dietary risk assessment for trifluoroacetic acid (TFA) 
Status of the active substance: Code no.
LOQ (mg/kg bw): 0,01 proposed LOQ:
ADI (mg/kg bw/day): 0,05 ARfD (mg/kg bw): 0,05
Source of ADI: EFSA Source of ARfD: EFSA
Year of evaluation: 2014 Year of evaluation: 2014
1 5
No of diets exceeding ADI: ---
Highest calculated 
TMDI values in % 
of ADI  MS Diet
Highest contributor 
to MS diet 
(in % of ADI)
2nd contributor to 
MS diet 
(in % of ADI)
3rd contributor to 
MS diet 
(in % of ADI)
Commodity / 
group of commodities
pTMRLs at 
LOQ
(in % of ADI)
5,0 DE child 1,9 0,7 0,6 Oranges 0,0
4,8 WHO Cluster diet B  1,4 0,4 0,4 Maize 0,1
4,2 NL child 1,0 0,8 0,5 Oranges 0,0
3,6 IE adult 0,4 0,4 0,2 Wine grapes 0,1
3,0 DK child 0,9 0,7 0,4 Apples 0,0
2,9 FR toddler 0,4 0,4 0,4 Beans (with pods) 0,0
2,8 UK Toddler 0,6 0,5 0,3 Oranges 0,5
2,8 WHO cluster diet E 0,6 0,3 0,2 Soya bean 0,0
2,6 WHO cluster diet D 1,0 0,1 0,1 Potatoes 0,0
2,5 PT General population 0,6 0,4 0,2 Potatoes 0,0
2,4 IT kids/toddler 1,1 0,2 0,2 Tomatoes 0,0
2,4 UK Infant  0,4 0,3 0,2 Bananas 0,2
2,3 ES child 0,7 0,3 0,2 Apples 0,0
2,2 WHO Cluster diet F  0,6 0,2 0,1 Oranges 0,0
2,2 SE  general population 90th percentile 0,5 0,3 0,2 Apples 0,0
2,0 WHO regional European diet  0,5 0,1 0,1 Potatoes 0,0
1,9 FR all population 0,6 0,5 0,1 Apples 0,0
1,8 NL general 0,3 0,2 0,2 Apples 0,0
1,8 FR infant 0,4 0,3 0,1 Oranges 0,0
1,8 IT adult 0,7 0,2 0,1 Apples 0,0
1,6 ES adult 0,4 0,2 0,1 Apples 0,0
1,5 UK vegetarian 0,3 0,1 0,1 Wine grapes 0,1
1,3 DK adult 0,3 0,2 0,1 Apples 0,0
1,2 UK Adult  0,3 0,2 0,1 Oranges 0,1
1,1 LT adult 0,3 0,2 0,2 Wheat 0,0
0,9 PL  general population 0,3 0,1 0,1 Potatoes 0,0
0,9 FI  adult 0,2 0,2 0,1 Rye 0,0
Tomatoes
Oranges
Wheat Oranges
Tomatoes
Oranges
Wine grapes
Wine grapes
Rye
Soya bean
Bananas
Tomatoes
Wheat
Oranges
Beans (with pods)
SUGAR PLANTS
Wine grapes
Tomatoes
Wine grapes
Other cereal
Apples
Wheat
Tomatoes
Wheat
Maize
Rye
Apples
Commodity / 
group of commodities
Commodity / 
group of commodities
Apples
Wheat
Trifluoroacetic acid (TFA)
Toxicological end points
                     TMDI (range) in % of ADI
                        minimum - maximum
Chronic risk assessment - refined calculations
Conclusion:
The estimated Theoretical Maximum Daily Intakes (TMDI), based on pTMRLs were below the ADI. 
A long-term intake of residues of  Trifluoroacetic acid (TFA) is unlikely to present a public health concern.
Wheat
Wheat
Wheat
Wheat
Apples
Maize
Wheat
Apples
Wheat
Wheat
Wine grapes
Wheat
Wheat
Wheat
Wheat
Wheat
Oranges
Wheat
Wheat
Apples
Apples
Apples
Wheat
Wheat
Wheat
Prepare workbook for refined 
calculations
Undo refined calculations
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The acute risk assessment is based on the ARfD.
--- --- --- ---
IESTI 1 *) **) IESTI 2 *) **) IESTI 1 *) **) IESTI 2 *) **)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
24,6 Potatoes 0,08 / - 17,6 Potatoes 0,08 / - 5,1 Table grapes 0,08 / - 5,1 Table grapes 0,08 / -
21,2 Oranges 0,08 / - 15,3 Oranges 0,08 / - 4,8 Potatoes 0,08 / - 4,7 Mangoes 0,08 / -
15,7 Apples 0,08 / - 14,3 Grapefruit  0,08 / - 4,7 Mangoes 0,08 / - 3,8 Wine grapes 0,08 / -
14,6 Pears 0,08 / - 11,6 Apples 0,08 / - 4,1 Oranges 0,08 / - 3,7 Potatoes 0,08 / -
14,3 Grapefruit  0,08 / - 10,5 Pears 0,08 / - 3,8 Wine grapes 0,08 / - 3,3 Oranges 0,08 / -
13,4 Bananas 0,08 / - 10,5 Table grapes 0,08 / - 3,6 Apples 0,08 / - 3,0 Apples 0,08 / -
12,6 Mangoes 0,08 / - 9,7 Bananas 0,08 / - 3,5 Sweet corn 0,08 / - 2,6 Pears 0,08 / -
11,7 Sweet corn 0,08 / - 9,0 Mangoes 0,08 / - 3,4 Pears 0,08 / - 2,5 Sweet corn 0,08 / -
10,5 Table grapes 0,08 / - 8,4 Sweet corn 0,08 / - 3,2 Grapefruit  0,08 / - 2,4 Grapefruit  0,08 / -
9,5 Peaches 0,08 / - 7,0 Peaches 0,08 / - 2,8 Peaches 0,08 / - 2,2 Peaches 0,08 / -
8,9 Mandarins  0,08 / - 6,7 Mandarins  0,08 / - 2,2 Bananas 0,08 / - 2,1 Beans 0,165 / -
6,0 Beans 0,165 / - 6,0 Beans 0,165 / - 2,1 Mandarins  0,08 / - 2,0 Pumpkins 0,019 / -
5,8 Melons 0,019 / - 5,8 Melons 0,019 / - 2,1 Beans 0,165 / - 1,7 Beans (with pods) 0,165 / -
5,5 Lemons 0,08 / - 4,6 Watermelons 0,019 / - 2,0 Pumpkins 0,019 / - 1,7 Bananas 0,08 / -
5,3 Plums 0,08 / - 4,3 Plums 0,08 / - 1,7 Beans (with pods) 0,165 / - 1,7 Beans (without pods) 0,165 / -
5,0 Apricots 0,08 / - 4,1 Lemons 0,08 / - 1,7 Beans (without pods) 0,165 / - 1,7 Mandarins  0,08 / -
4,6 Watermelons 0,019 / - 4,0 Apricots 0,08 / - 1,5 Watermelons 0,019 / - 1,5 Watermelons 0,019 / -
3,7 Beans (with pods) 0,165 / - 3,7 Beans (with pods) 0,165 / - 1,5 Plums 0,08 / - 1,5 Melons 0,019 / -
3,3 Scarole (broad-leaf 
endive)
0,019 / - 3,3 Scarole (broad-leaf 
endive)
0,019 / - 1,5 Melons 0,019 / - 1,4 Chinese cabbage 0,019 / -
3,2 Limes 0,08 / - 2,7 Peas (without 
pods)
0,165 / - 1,4 Chinese cabbage 0,019 / - 1,3 Peas (without pods) 0,165 / -
2,7 Peas (without pods) 0,165 / - 2,5 Cauliflower 0,019 / - 1,3 Quinces 0,08 / - 1,3 Wheat 0,08 / -
2,6 Kale 0,019 / - 2,3 Wheat 0,08 / - 1,3 Peas (without pods) 0,165 / - 1,2 Plums 0,08 / -
2,5 Cauliflower 0,019 / - 2,3 Limes 0,08 / - 1,3 Wheat 0,08 / - 1,2 Cauliflower 0,019 / -
No of critical MRLs (IESTI 1) --- No of critical MRLs (IESTI 2) ---
--- ---
***) ***)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
No of commodities for which 
ARfD/ADI is exceeded:
No of commodities for which ARfD/ADI 
is exceeded:
Threshold MRL is the  calculated residue level which would leads to an exposure equivalent to 100 % of the ARfD.  
No of commodities for which ARfD/ADI 
is exceeded (IESTI 1):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 2):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 1):
For Trifluoroacetic acid (TFA) IESTI 1 and IESTI 2 were calculated for food commodities for which pTMRLs were submitted and for which consumption data are available.
In the IESTI 1 calculation, the variability factors were 10, 7 or 5 (according to JMPR manual 2002), for lettuce a variability factor of 5 was used. 
In the IESTI 2 calculations, the variability factors of 10 and 7 were replaced by 5. For lettuce the calculation was performed with a variabilty factor of 3.  
No of commodities for which ARfD/ADI is 
exceeded (IESTI 2):
For each commodity the calculation is based on the highest reported MS consumption per kg bw and the corresponding unit weight from the MS with the critical consumption. If no data on the unit weight was available from that MS an average 
European unit weight was used for the IESTI calculation. 
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*) The results of the IESTI calculations are reported for at least 5 commodities. If the ARfD is exceeded for more than 5 commodities, all IESTI values > 90% of ARfD are reported. 
**) pTMRL: provisional temporary MRL
***) pTMRL: provisional temporary MRL for unprocessed commodity
No exceedance of the ARfD/ADI was identified for any unprocessed commodity. 
 
Acute risk assessment /children - refined calculations Acute risk assessment / adults / general population - refined calculations
Conclusion:
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ABBREVIATIONS 
ADI  acceptable daily intake 
ARfD  acute reference dose 
a.s.  active substance 
BBCH  growth stages of mono- and dicotyledonous plants 
bw  body weight 
CAC  Codex Alimentarius Commission 
CCPR  Codex Committee on Pesticide Residues 
CF  conversion  factor  for  enforcement  residue  definition  to  risk  assessment 
residue definition 
cGAP  critical GAP 
CIPAC  Collaborative International Pesticide Analytical Council 
CXL  Codex Maximum Residue Limit (Codex MRL) 
d  day 
DAR  Draft Assessment Report  
DAT  days after treatment 
DM  dry matter 
EFSA  European Food Safety Authority 
EMS  evaluating Member State 
eq  residue expressed as a.s. equivalent 
EU  European Union 
FAO  Food and Agriculture Organisation of the United Nations 
GAP  good agricultural practice 
GCPF  Global Crop Protection Federation (former GIFAP) 
GS  growth stage 
ha  hectare 
hL  hectolitre 
HR  highest residue 
i.p.  intraperitoneal  
ISO  International Organisation for Standardisation 
IUPAC  International Union of Pure and Applied Chemistry 
JMPR  Joint FAO/WHO Meeting on Pesticide Residues 
kg  kilogram 
L  litre 
LOAEL  lowest observed adverse effect level Setting of MRLs for saflufenacil and dietary risk assessment for its metabolite TFA  
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LOD  limit of detection 
LOQ  limit of quantification  
MRL  maximum residue level  
MS  Member States 
NEU  northern European Union 
NOAEL  no observed adverse effect level 
MW  molecular weight 
OECD  Organisation for Economic Co-operation and Development 
PF  processing factor 
PHI  pre-harvest interval 
PND  post-natal day 
PRIMo  (EFSA) Pesticide Residues Intake Model 
RD  residue definition 
RMS  rapporteur Member State 
SANCO  Directorate-General for Health and Consumers  
SCFCAH  Standing Committee on the Food Chain and Animal Health 
SEU  Southern European Union 
STMR  supervised trials median residue 
TFA  
TFAA 
Trifluoroacetic acid 
TMDI  theoretical maximum daily intake 
TRR  total radioactive residue 
WHO  World Health Organization 
yr  year 
 